629 results on '"H. Hosoda"'
Search Results
202. Hippocampal clock regulates memory retrieval via Dopamine and PKA-induced GluA1 phosphorylation.
- Author
-
Hasegawa S, Fukushima H, Hosoda H, Serita T, Ishikawa R, Rokukawa T, Kawahara-Miki R, Zhang Y, Ohta M, Okada S, Tanimizu T, Josselyn SA, Frankland PW, and Kida S
- Subjects
- ARNTL Transcription Factors genetics, ARNTL Transcription Factors metabolism, Animals, Cyclic AMP metabolism, Cyclic AMP-Dependent Protein Kinases genetics, Cyclic AMP-Dependent Protein Kinases metabolism, Dopamine metabolism, Female, Gene Knock-In Techniques, Male, Maze Learning, Mice, Mice, Transgenic, Models, Animal, Phosphorylation physiology, Circadian Clocks physiology, Hippocampus metabolism, Mental Recall physiology, Receptors, AMPA metabolism
- Abstract
Cognitive performance in people varies according to time-of-day, with memory retrieval declining in the late afternoon-early evening. However, functional roles of local brain circadian clocks in memory performance remains unclear. Here, we show that hippocampal clock controlled by the circadian-dependent transcription factor BMAL1 regulates time-of-day retrieval profile. Inducible transgenic dominant negative BMAL1 (dnBMAL1) expression in mouse forebrain or hippocampus disrupted retrieval of hippocampal memories at Zeitgeber Time 8-12, independently of retention delay, encoding time and Zeitgeber entrainment cue. This altered retrieval profile was associated with downregulation of hippocampal Dopamine-cAMP signaling in dnBMAL1 mice. These changes included decreases in Dopamine Receptors (D1-R and D5-R) and GluA1-S845 phosphorylation by PKA. Consistently, pharmacological activation of cAMP-signals or D1/5Rs rescued impaired retrieval in dnBMAL1 mice. Importantly, GluA1 S845A knock-in mice showed similar retrieval deficits with dnBMAL1 mice. Our findings suggest mechanisms underlying regulation of retrieval by hippocampal clock through D1/5R-cAMP-PKA-mediated GluA1 phosphorylation.
- Published
- 2019
- Full Text
- View/download PDF
203. Plaque erosion or coronary artery embolism? Findings from clinical presentation, optical coherence tomographic and histopathological analysis in a case with acute coronary syndrome.
- Author
-
Kitahara S, Kataoka Y, Otsuka F, Hosoda H, Asaumi Y, Noguchi T, and Yasuda S
- Subjects
- Aged, 80 and over, Coronary Angiography, Coronary Artery Disease complications, Diagnosis, Differential, Embolism complications, Female, Humans, Plaque, Atherosclerotic, Predictive Value of Tests, ST Elevation Myocardial Infarction diagnostic imaging, ST Elevation Myocardial Infarction etiology, Coronary Artery Disease diagnostic imaging, Coronary Artery Disease pathology, Coronary Vessels diagnostic imaging, Coronary Vessels pathology, Embolism diagnostic imaging, Embolism pathology, Tomography, Optical Coherence
- Published
- 2019
- Full Text
- View/download PDF
204. Metabolism of atrial and brain natriuretic peptides in the fetoplacental circulation of fetuses with congenital heart diseases.
- Author
-
Miyoshi T, Hosoda H, Miyazato M, Kangawa K, Yoshimatsu J, and Minamino N
- Subjects
- Arrhythmias, Cardiac blood, Arrhythmias, Cardiac congenital, Biomarkers blood, Case-Control Studies, Cross-Sectional Studies, Female, Gene Expression, Humans, Infant, Newborn, Male, Placenta metabolism, Pregnancy, Prospective Studies, Receptors, Atrial Natriuretic Factor genetics, Umbilical Arteries metabolism, Umbilical Veins metabolism, Atrial Natriuretic Factor blood, Heart Defects, Congenital blood, Natriuretic Peptide, Brain blood, Placental Circulation
- Abstract
Introduction: Natriuretic peptides (NPs) play a pivotal role in maintaining fetal circulation; however, little is known about their metabolism. The aim of the present study was to elucidate the metabolism of plasma NPs in the fetoplacental circulation., Methods: Plasma NP concentrations in maternal vein and umbilical artery (UA) and vein (UV) samples from fetuses with congenital heart defect (n = 86) or arrhythmia (n = 31) and controls (n = 127) were analyzed., Results: Levels of plasma atrial NP (ANP) and brain NP (BNP) showed good correlation between UV versus UA samples (p < 0.01). In all three fetus groups, the regression coefficients between UV and UA plasma ANP levels were close to 0.5, while those between UV and UA plasma BNP levels were close to 1. The molecular forms of immunoreactive ANP in UA plasma showed a single peak corresponding to mature ANP, while those of immunoreactive BNP in UA plasma showed two major peaks and several minor peaks corresponding to mature BNP-32 and its partially digested peptides, as well as glycosylated and non-glycosylated BNP precursors (proBNP). No correlation was found between fetuses and mothers in terms of either plasma ANP or BNP levels., Conclusions: The mother and fetus independently secrete and metabolize both ANP and BNP. Fetal plasma ANP consists exclusively of the mature form, and the placenta and umbilical vessels are possible major sites of ANP metabolism. In contrast, fetal plasma BNP consists predominantly of the precursor forms, which may contribute to protecting BNP from metabolism in the fetoplacental circulation., (Copyright © 2019 Elsevier Ltd. All rights reserved.)
- Published
- 2019
- Full Text
- View/download PDF
205. Postoperative decrease in plasma acyl ghrelin levels after pediatric living donor liver transplantation in association with hepatic damage due to ischemia and reperfusion injury.
- Author
-
Zenitani M, Hosoda H, Kodama T, Saka R, Takama Y, Ueno T, Tazuke Y, Kangawa K, Oue T, and Okuyama H
- Subjects
- Aspartate Aminotransferases blood, Case-Control Studies, Child, Female, Humans, Living Donors, Male, Postoperative Period, Time Factors, Ghrelin blood, Liver Transplantation, Reperfusion Injury blood
- Abstract
Purpose: Ghrelin was recently reported to promote recovery from hepatic injury. We hypothesized that it could also be associated with clinical recovery of the transplanted liver from ischemia and reperfusion injury. Our aims were to investigate perioperative ghrelin changes following pediatric living donor liver transplantation (LDLT) and to analyze the association of these changes with postoperative hepatic function., Methods: We measured plasma acyl ghrelin (AG) concentrations before surgery, at the end of surgery and on postoperative days (PODs) 1, 3 and 7 in 12 children who underwent LDLTs, and, as controls, pre- and post-operatively and on POD1 in 7 children who underwent benign abdominal mass resection. The correlations between the participants' ghrelin profiles and hepatic function-related data were evaluated., Results: AG levels significantly declined to 15.6% of preoperative levels after LDLT and almost returned to baseline on POD3. Post-operative AG levels were significantly reduced to a greater extent following LDLT than benign abdominal mass resection. AG levels on POD1 inversely correlated with aspartate aminotransferase levels and cold/total ischemia time (P < 0.05)., Conclusion: These results suggest that reduced AG levels on POD1 may reflect the degree of damage to the transplanted liver due to ischemia and reperfusion injury.
- Published
- 2019
- Full Text
- View/download PDF
206. Severely calcified lipidic atheroma on intravascular ultrasound and near-infrared spectroscopy imaging: its association with slow-flow phenomenon during percutaneous coronary intervention.
- Author
-
Hosoda H, Kataoka Y, Otsuka F, and Yasuda S
- Published
- 2019
- Full Text
- View/download PDF
207. Characteristics of gas from the fluidized bed gasification of refuse paper and plastic fuel (RPF) and wood biomass.
- Author
-
Win MM, Asari M, Hayakawa R, Hosoda H, Yano J, and Sakai SI
- Subjects
- Biomass, Gases, Japan, Plastics, Wood
- Abstract
Energy recovery from small and medium scale waste thermal treatment facilities in the municipalities of Japan is challenging, owing to low power generation efficiency and high economic demands. Gas Engine (GE) generation is considered an efficient resource utilization method in these facilities. In this study, new and consistent feedstock, Refuse Paper and Plastic Fuel (RPF), and wood pellets were tested in an air-blown Fluidized Bed Gasifier (FBG) for syngas utilization in a GE. With temperatures ranging from 700 to 940 °C and varying Equivalence Ratios (ER) of 0.3-0.5, some of the most important product gas characteristics were analyzed, including the Lower Heating Value (LHV) and tar concentration levels. Gas composition results revealed that the concentration tendencies varied for the product gases CO, H
2 , and hydrocarbons, depending on the feedstock type, whereas the same tendencies were observed for CH4 and tar concentrations. Through the ER range, the LHV of product gas for RPF and wood pellets was 3.4-5.9 MJ/Nm3 . Tar concentrations decreased to 2.5-14.0 g/Nm3 -dry as the ER was raised. The optimal ER for LHV performance in GE generation was approximately 0.4 for RPF and wood pellets, and remaining tar concentrations were about 5.0 g/Nm3 -dry at the gasifier exit., (Copyright © 2019 Elsevier Ltd. All rights reserved.)- Published
- 2019
- Full Text
- View/download PDF
208. Magnetic field-induced rubber-like behavior in Ni-Mn-Ga particles/polymer composite.
- Author
-
Sratong-On P, Chernenko VA, Feuchtwanger J, and Hosoda H
- Abstract
Single crystalline Ni-Mn-Ga is well known as a prototype ferromagnetic shape memory alloy (FSMA) exhibiting a giant magnetic field-induced strain (MFIS), up to 12%, due to the magnetically driven twin boundary rearrangement. The large stroke and fast magnetomechanical response make it important for actuators and sensors. Polycrystalline Ni-Mn-Ga is inexpensive and technologically easy accessible, but constrains from the grain boundaries inhibit the twin boundary motion, whereby a very low MFIS is observed. Here, we have shown for the first time that a polycrystalline Ni-Mn-Ga can be split into the magnetostrain-active single grains which, being specially assembled in a silicone polymer matrix, caused large and fully reversible MFIS of the resulting composite. We termed the unique reversibility of a large MFIS of the composite as the magnetic field-induced rubber-like behavior. The magnetostrain of individual particles was explored by the X-ray μCT 3D imaging. The results suggest novel solutions for development of the low cost magnetic actuators and sensors for haptic applications.
- Published
- 2019
- Full Text
- View/download PDF
209. NSP-C contributes to the upregulation of CLOCK/BMAL1-mediated transcription.
- Author
-
Hosoda H and Kida S
- Abstract
The bHLH-PAS transcription factors clock circadian regulator (CLOCK) and brain and muscle ARNT-like protein 1 (BMAL1) play essential roles in the generation of circadian gene expression rhythms through the activation of E-box-mediated transcription. Importantly, circadian transcriptional rhythms mediated by CLOCK/BMAL1 are observed in peripheral tissues as well as in the suprachiasmatic nucleus and contribute to tissue-specific functions. These findings suggest that CLOCK/BMAL1 have roles in many biological phenomena by interacting with various cellular regulators. In the present study, to understand the mechanisms underlying the multiple functional roles of CLOCK, we tried to identify new proteins that interact with CLOCK using a yeast two-hybrid system. We identified neuroendocrine-specific protein (NSP)-C, which is highly expressed in the brain, as a positive regulator of CLOCK/BMAL1-mediated transcription. We found that NSP-C interacted with CLOCK in mammalian cells. Co-expression of NSP-C with CLOCK/BMAL1 enhanced the transcriptional activation by CLOCK/BMAL1. Furthermore, knockdown of endogenous NSP-C by small interfering RNA (siRNA) suppressed E-box-mediated transcription, while this reduction of transcription was rescued by the expression of NSP-C protected from the action of siRNA. These observations suggest that NSP-C contributes to the upregulation of CLOCK/BMAL1-mediated transcription.
- Published
- 2019
- Full Text
- View/download PDF
210. Tadalafil treatment in mice for preeclampsia with fetal growth restriction has neuro-benefic effects in offspring through modulating prenatal hypoxic conditions.
- Author
-
Tachibana R, Umekawa T, Yoshikawa K, Owa T, Magawa S, Furuhashi F, Tsuji M, Maki S, Shimada K, Kaneda MK, Nii M, Tanaka H, Tanaka K, Kamimoto Y, Kondo E, Kato I, Ikemura K, Okuda M, Ma N, Miyoshi T, Hosoda H, Endoh M, Kimura T, and Ikeda T
- Subjects
- Animals, Basic Helix-Loop-Helix Transcription Factors analysis, Brain pathology, Disease Models, Animal, Female, Mice, Placenta pathology, Pregnancy, Treatment Outcome, Fetal Growth Retardation prevention & control, Hypoxia prevention & control, Pre-Eclampsia drug therapy, Tadalafil administration & dosage, Vasodilator Agents administration & dosage
- Abstract
We have demonstrated that tadalafil facilitates fetal growth in mice with L-NG-nitroarginine methyl ester (L-NAME)-induced preeclampsia (PE) with fetal growth restriction (FGR). Tadalafil is a selective phosphodiesterase 5 inhibitor that dilates the maternal blood sinuses in the placenta, thereby facilitating the growth of the fetus. The purpose of this study was to investigate the effects of tadalafil treatment for PE and FGR on the developing brain in FGR offspring using an L-NAME-induced mouse model of PE with FGR. A control group of dams received carboxymethylcellulose (CMC). L-NAME-treated groups received L-NAME dissolved in CMC from 11 days post coitum (d.p.c.). The L-NAME-treated dams were divided into two subgroups 14 d.p.c. One subgroup continued to receive L-NAME. The other subgroup received L-NAME with tadalafil suspended in CMC. Tadalafil treatment for PE with FGR reduced the expression of hypoxia-inducible factor-2α in the placenta and in the brain of the FGR fetus. Moreover, tadalafil treatment in utero shows improved synaptogenesis and myelination in FGR offspring on postnatal day 15 (P15) and P30. These results suggest that tadalafil treatment for PE with FGR not only facilitates fetal growth, but also has neuroprotective effects on the developing brain of FGR offspring through modulating prenatal hypoxic conditions.
- Published
- 2019
- Full Text
- View/download PDF
211. Maternal biomarkers for fetal heart failure in fetuses with congenital heart defects or arrhythmias.
- Author
-
Miyoshi T, Hosoda H, Nakai M, Nishimura K, Miyazato M, Kangawa K, Ikeda T, Yoshimatsu J, and Minamino N
- Subjects
- Biomarkers blood, Cross-Sectional Studies, Elapid Venoms, Female, Fetal Blood, Fetal Diseases physiopathology, Fetal Heart diagnostic imaging, Gestational Age, Heart Failure physiopathology, Humans, Incidence, Multivariate Analysis, Natriuretic Peptide, C-Type, Pregnancy, Pregnancy Trimester, Second, Pregnancy Trimester, Third, ROC Curve, Risk Assessment, Fetal Diseases diagnostic imaging, Fetal Heart physiopathology, Heart Defects, Congenital diagnosis, Heart Failure diagnostic imaging, Pregnancy Outcome, Ultrasonography, Prenatal
- Abstract
Background: Diagnosis of fetal heart failure depends primarily on fetal ultrasonography assessment. Our recent study demonstrated that plasma natriuretic peptide levels in umbilical cord blood were correlated with the severity of heart failure in fetuses with congenital heart defects or arrhythmias. However, percutaneous umbilical blood sampling is an invasive procedure, and therefore, less or noninvasive biomarkers reflecting fetal heart failure are required., Objective: The aim of this study was to investigate the possibility of whether maternal serum biomarkers can diagnose fetal heart failure in fetuses with congenital heart defects or arrhythmias., Study Design: This exploratory cross-sectional study was conducted at a tertiary pediatric cardiac center. A total of 50 singletons with fetal congenital heart defects or arrhythmias and 50 controls who were registered in the National Cerebral and Cardiovascular Center Biobank from 2013 to 2016 were included. Maternal serum samples obtained during the third trimester were analyzed for 2 hormones and 36 cytokines using the Bio-Plex Pro Human Cancer Biomarker panels 1 and 2. We comprehensively analyzed the association between maternal serum biomarkers and ultrasonography findings or fetal arrhythmia status. Fetal heart failure was defined as a cardiovascular profile score ≤7., Results: Of 37 fetuses with congenital heart defects, heart failure was found in 1 case of tricuspid valve dysplasia with moderate tricuspid regurgitation. Of 13 fetuses with arrhythmias, 5 had heart failure at 28-33 weeks of gestation. Maternal serum cytokine and hormone concentrations were compared between patients with and without fetal heart failure at 28-33 weeks of gestation (n = 6 and n = 61, respectively). Sixty-one fetuses without heart failure consisted of 10 with congenital heart defect, 6 with arrhythmia, and 45 controls. Maternal serum concentrations of tumor necrosis factor-α, interleukin-6, soluble Fas ligand, transforming growth factor-α, and vascular endothelial growth factor-D were significantly higher when fetuses had heart failure than when they did not (P < .05), whereas maternal serum concentrations of heparin-binding epidermal growth factor-like growth factor were significantly lower when fetuses had heart failure than when they did not (P < .05). Multivariate analysis showed that maternal serum concentrations of tumor necrosis factor-α, vascular endothelial growth factor-D, and heparin-binding epidermal growth factor-like growth factor were independently associated with fetal heart failure. The cutoff values were as follows: tumor necrosis factor-α, 68 pg/mL (sensitivity of 50.0%, specificity of 93.4%, positive likelihood ratio of 7.6, negative likelihood ratio of 0.5); vascular endothelial growth factor-D, 1156 pg/mL (sensitivity of 50.0%, specificity of 93.4%, positive likelihood ratio of 7.6, negative likelihood ratio of 0.5); and heparin-binding epidermal growth factor-like growth factor, 90 pg/mL (sensitivity of 83.3%, specificity of 83.6%, positive likelihood ratio of 5.1, negative likelihood ratio of 0.2). The combination of these 3 cytokines showed sensitivity of 100%, specificity of 80.3%, positive likelihood ratio of 5.1, and negative likelihood ratio of 0. In the absence of fetal heart failure, concentrations of all maternal serum cytokines and hormones were similar in cases of fetal congenital heart defects and controls, while maternal serum soluble CD40 ligand concentrations were increased only in fetal arrhythmias., Conclusion: Maternal serum concentrations of tumor necrosis factor-α, vascular endothelial growth factor-D, and heparin-binding epidermal growth factor-like growth factor were associated with fetal heart failure., (Copyright © 2018. Published by Elsevier Inc.)
- Published
- 2019
- Full Text
- View/download PDF
212. Plasma natriuretic peptide levels in fetuses with congenital heart defect and/or arrhythmia.
- Author
-
Miyoshi T, Umekawa T, Hosoda H, Asada T, Fujiwara A, Kurosaki KI, Shiraishi I, Nakai M, Nishimura K, Miyazato M, Kangawa K, Ikeda T, Yoshimatsu J, and Minamino N
- Subjects
- Adult, Arrhythmias, Cardiac congenital, Cohort Studies, Female, Heart Failure congenital, Humans, Predictive Value of Tests, Pregnancy, Pregnancy Outcome, Prospective Studies, Arrhythmias, Cardiac blood, Biomarkers blood, Heart Defects, Congenital blood, Heart Failure blood, Natriuretic Peptides blood, Prenatal Diagnosis
- Abstract
Objective: Diagnosing fetal heart failure remains challenging because it is difficult to know how well the fetal myocardium will perform as loading conditions change. In adult cardiology, natriuretic peptides (NPs) are established markers of heart failure. However, the number of studies investigating NP levels in fetuses is quite limited. The aim of this study was to evaluate the significance of plasma NP levels in the assessment of heart failure in fetuses with a congenital heart defect (CHD) and/or arrhythmia., Methods: This was a prospective observational study conducted at a tertiary pediatric cardiac center. A total of 129 singletons with CHD and/or arrhythmia and 127 controls were analyzed between 2012 and 2015. Umbilical cord plasma atrial NP, brain NP and N-terminal pro-brain NP levels at birth were compared with ultrasonography findings indicating fetal heart failure, such as cardiovascular profile (CVP) score and morphological characteristics., Results: Fetuses with CHD and/or arrhythmia had higher NP levels than did controls (P < 0.01). NP levels of fetuses with CHD and/or arrhythmia were correlated inversely with CVP score (P for trend < 0.01). No differences in NP levels were found in fetuses with CHD and/or arrhythmia and a CVP score of ≥ 8 in comparison to controls. Multivariate analysis showed that a CVP score of ≤ 5, tachy- or bradyarrhythmia at birth, preterm birth and umbilical artery pH < 7.15 were associated independently with high NP levels (P < 0.01). Among fetuses with a CVP score of ≤ 7, abnormal venous Doppler sonography findings were significantly more common and more severe in fetuses with tachy- or bradyarrhythmia than in those with CHD, and those with tachy- or bradyarrhythmia had higher NP levels than did those with CHD (P = 0.01). Fetuses with right-heart defect and moderate or severe tricuspid valve regurgitation had significantly higher NP levels than did fetuses with other types of CHD (P < 0.01)., Conclusions: Plasma NP levels in fetuses with CHD and/or arrhythmia are correlated with the severity of fetal heart failure. Elevated NP levels are attributed mainly to an increase in central venous pressure secondary to arrhythmia or atrioventricular valve regurgitation due to CHD, rather than to the morphological abnormality itself. Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd., (Copyright © 2017 ISUOG. Published by John Wiley & Sons Ltd.)
- Published
- 2018
- Full Text
- View/download PDF
213. Brillouin characterization of slimmed polymer optical fibers for strain sensing with extremely wide dynamic range.
- Author
-
Mizuno Y, Matsutani N, Hayashi N, Lee H, Tahara M, Hosoda H, and Nakamura K
- Abstract
To date, most distributed Brillouin sensors for structural health monitoring have employed glass optical fibers as sensing fibers, but they are inherently fragile and cannot withstand strains of >3%. This means that the maximal detectable strain of glass-fiber-based Brillouin sensors was ~3%, which is far from being sufficient for monitoring the possible distortion caused by big earthquakes. To extend this strain dynamic range, polymer optical fibers (POFs) have been used as sensing fibers. As POFs can generally withstand even ~100% strain, at first, Brillouin scattering in POFs was expected to be useful in measuring such large strain. However, the maximal detectable strain using Brillouin scattering in POFs was found to be merely ~5%, because of a Brillouin-frequency-shift hopping phenomenon accompanied by a slimming effect peculiar to polymer materials. This conventional record of the strain dynamic range (5%) was still far from being sufficient. Here, we have thought of an idea that the strain dynamic range can be further extended by employing a POF with its whole length slimmed in advance and by avoiding the Brillouin-frequency-shift hopping. The experimental results reveal that, by applying 3.0% strain to a slimmed POF beforehand, we can achieve a >25% strain dynamic range, which is >5 times the conventional value and will greatly extend the application fields of fiber-optic Brillouin sensing.
- Published
- 2018
- Full Text
- View/download PDF
214. Amniotic Fluid Natriuretic Peptide Levels in Fetuses With Congenital Heart Defects or Arrhythmias.
- Author
-
Miyoshi T, Hosoda H, Umekawa T, Asada T, Fujiwara A, Kurosaki KI, Shiraishi I, Nakai M, Nishimura K, Miyazato M, Kangawa K, Ikeda T, Yoshimatsu J, and Minamino N
- Subjects
- Arrhythmias, Cardiac diagnosis, Case-Control Studies, Female, Heart Defects, Congenital diagnosis, Humans, Male, Pregnancy, Prospective Studies, Severity of Illness Index, Ultrasonography, Prenatal, Amniotic Fluid chemistry, Fetal Diseases diagnosis, Heart Failure diagnosis, Natriuretic Peptide, Brain analysis, Natriuretic Peptides analysis, Peptide Fragments analysis
- Abstract
Background: We have previously demonstrated that umbilical cord plasma natriuretic peptide (NP) levels reflect the severity of heart failure (HF) in fetuses with congenital heart defects (CHD). The aim of this study was to evaluate the significance of amniotic fluid (AF) NP levels in the assessment of HF in fetuses with CHD or arrhythmia., Methods and results: This was a prospective observational study at a tertiary pediatric cardiac center. A total of 95 singletons with CHD or arrhythmia, and 96 controls from 2012 to 2015 were analyzed. AF concentrations of atrial NP (ANP), B-type NP (BNP) and N-terminal pro-B-type NP (NT-proBNP) at birth were compared with ultrasonographic assessment of fetal HF using the cardiovascular profile (CVP) score. Multivariate analysis showed that a CVP score ≤5 and preterm birth are independently associated with high AF NT-proBNP levels. AF NT-proBNP levels of fetuses with CHD or arrhythmia inversely correlated with CVP score (P for trend <0.01). In contrast, AF concentrations of ANP and BNP were extremely low, and it was difficult to assess the degree of fetal HF based on them., Conclusions: AF NT-proBNP concentrations increase in stepwise fashion with the severity of HF in fetuses with CHD or arrhythmia; it was the optimal NP for assessing the fetal HF.
- Published
- 2018
- Full Text
- View/download PDF
215. C-type natriuretic peptide (CNP) in endothelial cells attenuates hepatic fibrosis and inflammation in non-alcoholic steatohepatitis.
- Author
-
Bae CR, Hino J, Hosoda H, Miyazato M, and Kangawa K
- Subjects
- Animals, Blood Glucose, Cells, Cultured, Endothelial Cells cytology, Glucose Tolerance Test, Inflammation etiology, Inflammation pathology, Insulin Resistance, Liver Cirrhosis etiology, Liver Cirrhosis pathology, Male, Mice, Mice, Transgenic, Non-alcoholic Fatty Liver Disease chemically induced, Choline Deficiency complications, Diet, High-Fat adverse effects, Endothelial Cells metabolism, Inflammation prevention & control, Liver Cirrhosis prevention & control, Natriuretic Peptide, C-Type metabolism, Non-alcoholic Fatty Liver Disease physiopathology
- Abstract
Aims: Our previous study revealed that mice transgenic for endothelial-cell-specific overexpression of CNP (E-CNP Tg mice) are protected against the increased fat weight, inflammation, and insulin resistance associated with high-fat diet (HFD)-induced obesity. In addition, E-CNP overexpression prevented abnormal lipid profiles and metabolism and blocked inflammation in the livers of HFD-fed mice. Because obesity, dyslipidemia, and insulin resistance increase the risk of various liver diseases, including non-alcoholic steatohepatitis (NASH), we here studied the role of E-CNP overexpression in the livers of mice in which NASH was induced through feeding of either HFD or a choline-deficient defined l‑amino-acid diet (CDAA)., Main Methods: Wild-type (Wt) and E-CNP Tg mice were fed either a standard diet or HFD for 25 weeks or CDAA for 10 weeks. We then assessed hepatic and serum biochemistry; measured blood glucose during glucose tolerance test (GTT) and insulin tolerance test (ITT); evaluated hepatic fibrosis and inflammation; and performed hepatic histology and gene expression analysis., Key Findings: Serum triglycerides, total cholesterol, non-esterified fatty acids, asparagine transaminase, glucose tolerance, and insulin resistance were ameliorated by CNP overexpression in endothelial cells of HFD-fed E-CNP Tg mice. In addition, hepatic fibrosis and inflammation were decreased in HFD-fed E-CNP Tg mice compared with HFD-fed Wt mice. CDAA-fed E-CNP Tg mice showed improved glycemic control, but liver parameters, fibrosis, and inflammation were remained elevated and equivalent to those in CDAA-fed Wt mice., Significance: The overexpression of CNP in endothelial cells has anti-fibrotic and anti-inflammatory effects in liver during HFD-induced NASH in mice., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
216. Angiotensin II promotes pulmonary metastasis of melanoma through the activation of adhesion molecules in vascular endothelial cells.
- Author
-
Ishikane S, Hosoda H, Nojiri T, Tokudome T, Mizutani T, Miura K, Akitake Y, Kimura T, Imamichi Y, Kawabe S, Toyohira Y, Yanagihara N, Takahashi-Yanaga F, Miyazato M, Miyamoto K, and Kangawa K
- Subjects
- Animals, Cell Proliferation drug effects, Cell Proliferation physiology, Dose-Response Relationship, Drug, Endothelial Cells drug effects, Endothelial Cells pathology, Lung Neoplasms pathology, Male, Melanoma, Experimental chemically induced, Melanoma, Experimental pathology, Mice, Mice, Inbred C57BL, Mice, Knockout, Random Allocation, Angiotensin II toxicity, Cell Adhesion Molecules metabolism, Endothelial Cells metabolism, Lung Neoplasms metabolism, Lung Neoplasms secondary, Melanoma, Experimental metabolism
- Abstract
Hypertension is considered as one of the cancer progressive factors, and often found comorbidity in cancer patients. Renin-angiotensin system (RAS) plays an important role in the regulation of blood pressure, and angiotensin II (Ang II) is well known pressor peptide associated with RAS. Ang II has been reported to accelerate progression and metastasis of cancer cells. However, its precise mechanisms have not been fully understood. In this study, we sought to elucidate the mechanisms by which Ang II exacerbates hematogenous metastasis in mouse melanoma cells, focusing the adhesion pathway in vascular endothelial cells. For this purpose, B16/F10 mouse melanoma cells, which do not express the Ang II type 1 receptor (AT1R), were intravenously injected into C57BL/6 mice. Two weeks after cell injection, the number of lung metastatic colonies was significantly higher in the Ang II-treated group (1 μg/kg/min) than in the vehicle-treated group. The AT1R blocker valsartan (40 mg/kg/day), but not the calcium channel blocker amlodipine (5 or 10 mg/kg/day), significantly suppressed the effect of Ang II. In endothelium-specific Agtr1a knockout mice, Ang II-mediated acceleration of lung metastases of melanoma cells was significantly diminished. Ang II treatment significantly increased E-selectin mRNA expression in vascular endothelial cells collected from lung tissues, and thus promoted adherence of melanoma cells to the vascular endothelium. Ang II-accelerated lung metastases of melanoma cells were also suppressed by treatment with anti-E-selectin antibody (20 mg/kg). Taken together, Ang II-treatment exacerbates hematogenous cancer metastasis by promoting E-selectin-mediated adhesion of cancer cells to vascular endothelial cells., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
217. Corrigendum to 'Atrial natriuretic peptide inhibits lipopolysaccharide-induced acute lung injury' [Pulm. Pharmacol. Therapeut. 29/1 (2014) 24-30].
- Author
-
Nojiri T, Hosoda H, Tokudome T, Miura K, Ishikane S, Kimura T, Shintani Y, Inoue M, Sawabata N, Miyazato M, Okumura M, and Kangawa K
- Published
- 2018
- Full Text
- View/download PDF
218. Chemotherapy can promote liver metastasis by enhancing metastatic niche formation in mice.
- Author
-
Zenitani M, Nojiri T, Hosoda H, Kimura T, Uehara S, Miyazato M, Okuyama H, and Kangawa K
- Subjects
- Animals, Bone Marrow drug effects, Calgranulin A genetics, Cell Line, Tumor, Cisplatin adverse effects, Humans, Liver Neoplasms chemically induced, Matrix Metalloproteinase 2 genetics, Mice, Mice, Inbred BALB C, Mice, Inbred C57BL, Neoplasms, Experimental pathology, Vincristine adverse effects, Antineoplastic Agents adverse effects, Liver Neoplasms secondary, Neoplasms, Experimental drug therapy
- Abstract
Background: Some chemotherapeutic agents have been reported to promote lung metastasis. However, there have been no reports regarding chemotherapy-induced liver metastasis. We hypothesized that chemotherapy might also enhance liver metastasis. The present study aimed to create a chemotherapy-enhanced liver metastasis mouse model and investigate its mechanism., Materials and Methods: Mice were pretreated with cisplatin, vincristine, or saline by intraperitoneal injection. Next, B16F10 mouse melanoma cells and BE(2)-C human neuroblastoma cells were injected into the spleens of C57BL/6 and BALB/c nu/nu mice, respectively, to induce experimental liver metastasis, and the number of liver nodules was determined. We also analyzed the effect of chemotherapy on changes of the liver tissue regarding representative metastasis-promoting factors using real-time quantitative polymerase chain reaction and immunohistochemical and histological analysis., Results: Cisplatin increased the number of nodules by 4.7-fold in the B16F10 liver metastasis model. Vincristine increased the number of nodules by 3.8-fold in the BE(2)-C liver metastasis model. Cisplatin increased mRNA levels of matrix-metalloproteinase (MMP)-2 and periostin, while vincristine increased MMP-9 and S100A8/9 levels in liver tissues. Cisplatin induced fibrosis, whereas vincristine induced neutrophil recruitment in liver tissues according to histological and immunohistochemical analysis., Conclusions: We concluded that cisplatin or vincristine could enhance liver metastasis of mouse melanoma cells or human neuroblastoma cells, respectively. In addition, the mRNA expression of MMP-2 and periostin, or MMP-9 and S100A8/9 is increased by cisplatin or vincristine pretreatment, possibly resulting in fibrosis or neutrophil recruitment, respectively. These niche factors might be associated with increased liver metastasis., (Copyright © 2017 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
219. Noninvasive Coronary Plaque Imaging.
- Author
-
Noguchi T, Nakao K, Asaumi Y, Morita Y, Otsuka F, Kataoka Y, Hosoda H, Miura H, Fukuda T, and Yasuda S
- Subjects
- Contrast Media, Coronary Artery Disease, Coronary Vessels diagnostic imaging, Heart diagnostic imaging, Humans, Coronary Angiography methods, Magnetic Resonance Angiography methods, Plaque, Atherosclerotic diagnostic imaging, Positron-Emission Tomography methods, Tomography, Optical Coherence methods, Tomography, X-Ray Computed methods, Ultrasonography, Interventional methods
- Abstract
Early identification of high-risk or vulnerable atherosclerotic plaques prone to rupture and performing preemptive therapy prior to catastrophic cardiovascular events are optimal goals of plaque imaging. Despite the advances in imaging modalities to identify vulnerable characteristics, the predictive value of the imaging techniques in the clinical setting is still developing. In this regard, reliable and high-sensitive imaging modalities identifying vulnerable plaque characters that may lead to future cardiovascular events will be useful. In this review article, we describe a current non-invasive plaque imaging technique to identify high-risk coronary plaque features.
- Published
- 2018
- Full Text
- View/download PDF
220. Ghrelin Pre-treatment Attenuates Local Oxidative Stress and End Organ Damage During Cardiopulmonary Bypass in Anesthetized Rats.
- Author
-
Sukumaran V, Tsuchimochi H, Fujii Y, Hosoda H, Kangawa K, Akiyama T, Shirai M, Tatsumi E, and Pearson JT
- Abstract
Cardiopulmonary bypass (CPB) induced systemic inflammation significantly contributes to the development of postoperative complications, including respiratory failure, myocardial, renal and neurological dysfunction and ultimately can lead to failure of multiple organs. Ghrelin is a small endogenous peptide with wide ranging physiological effects on metabolism and cardiovascular regulation. Herein, we investigated the protective effects of ghrelin against CPB-induced inflammatory reactions, oxidative stress and acute organ damage. Adult male Sprague Dawley rats randomly received vehicle ( n = 5) or a bolus of ghrelin (150 μg/kg, sc, n = 5) and were subjected to CPB for 4 h (protocol 1). In separate rats, ghrelin pre-treatment (protocol 2) was compared to two doses of ghrelin (protocol 3) before and after CPB for 2 h followed by recovery for 2 h. Blood samples were taken prior to CPB, and following CPB at 2 h and 4 h. Organ nitrosative stress (3-nitrotyrosine) was measured by Western blotting. CPB induced leukocytosis with increased plasma levels of tumor necrosis factor-α and interleukin-6 indicating a potent inflammatory response. Ghrelin treatment significantly reduced plasma organ damage markers (lactate dehydrogenase, aspartate aminotransferase, alanine aminotransferase) and protein levels of 3-nitrotyrosine, particularly in the brain, lung and liver, but only partly suppressed inflammatory cell invasion and did not reduce proinflammatory cytokine production. Ghrelin partially attenuated the CPB-induced elevation of epinephrine and to a lesser extent norepinephrine when compared to the CPB saline group, while dopamine levels were completely suppressed. Ghrelin treatment sustained plasma levels of reduced glutathione and decreased glutathione disulphide when compared to CPB saline rats. These results suggest that even though ghrelin only partially inhibited the large CPB induced increase in catecholamines and organ macrophage infiltration, it reduced oxidative stress and subsequent cell damage. Pre-treatment with ghrelin might provide an effective adjunct therapy for preventing widespread CPB induced organ injury.
- Published
- 2018
- Full Text
- View/download PDF
221. Adipocyte-specific expression of C-type natriuretic peptide suppresses lipid metabolism and adipocyte hypertrophy in adipose tissues in mice fed high-fat diet.
- Author
-
Bae CR, Hino J, Hosoda H, Son C, Makino H, Tokudome T, Tomita T, Hosoda K, Miyazato M, and Kangawa K
- Subjects
- Adipocytes cytology, Adipose Tissue pathology, Animals, Energy Metabolism, Hypertrophy etiology, Insulin Resistance, Lipolysis, Male, Mice, Mice, Inbred C57BL, Obesity etiology, Obesity prevention & control, Adipocytes metabolism, Adipose Tissue drug effects, Diet, High-Fat adverse effects, Hypertrophy prevention & control, Lipid Metabolism drug effects, Natriuretic Agents pharmacology, Natriuretic Peptide, C-Type pharmacology
- Abstract
C-type natriuretic peptide (CNP) is expressed in diverse tissues, including adipose and endothelium, and exerts its effects by binding to and activating its receptor, guanylyl cyclase B. Natriuretic peptides regulate intracellular cGMP and phosphorylated vasodilator-stimulated phosphoprotein (VASP). We recently revealed that overexpression of CNP in endothelial cells protects against high-fat diet (HFD)-induced obesity in mice. Given that endothelial CNP affects adipose tissue during obesity, CNP in adipocytes might directly regulate adipocyte function during obesity. Therefore, to elucidate the effect of CNP in adipocytes, we assessed 3T3-L1 adipocytes and transgenic (Tg) mice that overexpressed CNP specifically in adipocytes (A-CNP). We found that CNP activates the cGMP-VASP pathway in 3T3-L1 adipocytes. Compared with Wt mice, A-CNP Tg mice showed decreases in fat weight and adipocyte hypertrophy and increases in fatty acid β-oxidation, lipolysis-related gene expression, and energy expenditure during HFD-induced obesity. These effects led to decreased levels of the macrophage marker F4/80 in the mesenteric fat pad and reduced inflammation. Furthermore, A-CNP Tg mice showed improved glucose tolerance and insulin sensitivity, which were associated with enhanced insulin-stimulated Akt phosphorylation. Our results suggest that CNP overexpression in adipocytes protects against adipocyte hypertrophy, excess lipid metabolism, inflammation, and decreased insulin sensitivity during HFD-induced obesity.
- Published
- 2018
- Full Text
- View/download PDF
222. Effect of eicosapentaenoic acid/docosahexaenoic acid on coronary high-intensity plaques detected with non-contrast T1-weighted imaging (the AQUAMARINE EPA/DHA study): study protocol for a randomized controlled trial.
- Author
-
Nakao K, Noguchi T, Asaumi Y, Morita Y, Kanaya T, Fujino M, Hosoda H, Yoneda S, Kawakami S, Nagai T, Nishihira K, Nakashima T, Kumasaka R, Arakawa T, Otsuka F, Nakanishi M, Kataoka Y, Tahara Y, Goto Y, Yamamoto H, Hamasaki T, and Yasuda S
- Subjects
- Computed Tomography Angiography, Coronary Angiography methods, Coronary Artery Disease pathology, Coronary Vessels pathology, Docosahexaenoic Acids adverse effects, Drug Therapy, Combination, Eicosapentaenoic Acid adverse effects, Humans, Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use, Japan, Predictive Value of Tests, Prospective Studies, Randomized Controlled Trials as Topic, Time Factors, Treatment Outcome, Coronary Artery Disease diagnostic imaging, Coronary Artery Disease drug therapy, Coronary Vessels diagnostic imaging, Coronary Vessels drug effects, Docosahexaenoic Acids therapeutic use, Eicosapentaenoic Acid therapeutic use, Magnetic Resonance Imaging, Plaque, Atherosclerotic
- Abstract
Background: Despite the success of HMG-CoA reductase inhibitor (statin) therapy in reducing atherosclerotic cardiovascular events, a residual risk for cardiovascular events in patients with coronary artery disease (CAD) remains. Long-chain n-3 polyunsaturated fatty acids (LC n-3 PUFAs), especially eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are promising anti-atherosclerosis agents that might reduce the residual CAD risk. Non-contrast T1-weighted imaging (T1WI) with cardiac magnetic resonance (CMR) less invasively identifies high-risk coronary plaques as high-intensity signals. These high-intensity plaques (HIPs) are quantitatively assessed using the plaque-to-myocardium signal intensity ratio (PMR). Our goal is to assess the effect of EPA/DHA on coronary HIPs detected with T1WI in patients with CAD on statin treatment., Methods/design: This prospective, controlled, randomized, open-label study examines the effect of 12 months of EPA/DHA therapy and statin treatment on PMR of HIPs detected with CMR and computed tomography angiography (CTA) in patients with CAD. The primary endpoint is the change in PMR after EPA/DHA treatment. Secondary endpoints include changes in Hounsfield units, plaque volume, vessel area, and plaque area measured using CTA. Subjects are randomly assigned to either of three groups: the 2 g/day EPA/DHA group, the 4 g/day EPA/DHA group, or the no-treatment group., Discussion: This trial will help assess whether EPA/DHA has an anti-atherosclerotic effect using PMR of HIPs detected by CMR. The trial outcomes will provide novel insights into the effect of EPA/DHA on high-risk coronary plaques and may provide new strategies for lowering the residual risk in patients with CAD on statin therapy., Trial Registration: The University Hospital Medical Information Network (UMIN) Clinical Trials Registry, ID: UMIN000015316 . Registered on 2 October 2014.
- Published
- 2018
- Full Text
- View/download PDF
223. CORRIGENDUM: Amniotic Fluid Natriuretic Peptide Levels in Fetuses With Congenital Heart Defects or Arrhythmias.
- Author
-
Miyoshi T, Hosoda H, Umekawa T, Asada T, Fujiwara A, Kurosaki KI, Shiraishi I, Nakai M, Nishimura K, Miyazato M, Kangawa K, Ikeda T, Yoshimatsu J, and Minamino N
- Published
- 2018
- Full Text
- View/download PDF
224. Tadalafil Improves L-NG-Nitroarginine Methyl Ester-Induced Preeclampsia With Fetal Growth Restriction-Like Symptoms in Pregnant Mice.
- Author
-
Yoshikawa K, Umekawa T, Maki S, Kubo M, Nii M, Tanaka K, Tanaka H, Osato K, Kamimoto Y, Kondo E, Ikemura K, Okuda M, Katayama K, Miyoshi T, Hosoda H, Ma N, Yoshida T, and Ikeda T
- Subjects
- Animals, Blood Pressure drug effects, Cyclic GMP urine, Female, Fetal Development drug effects, Fetal Growth Retardation pathology, Kidney pathology, Mice, Mice, Inbred C57BL, Oxidative Stress drug effects, Placenta pathology, Pre-Eclampsia pathology, Pregnancy, Proteinuria chemically induced, Enzyme Inhibitors, Fetal Growth Retardation chemically induced, Fetal Growth Retardation prevention & control, NG-Nitroarginine Methyl Ester, Phosphodiesterase 5 Inhibitors therapeutic use, Pre-Eclampsia chemically induced, Pre-Eclampsia prevention & control, Tadalafil therapeutic use
- Abstract
Background: We investigated the efficacy and mechanisms of tadalafil, a selective phosphodiesterase 5 inhibitor, in treating preeclampsia (PE) with fetal growth restriction (FGR) using L-NG-nitroarginine methyl ester (L-NAME)-induced PE with FGR in pregnant mice as our experimental model., Methods: C57BL/6 mice were divided into 2 groups 11 days postcoitum (d.p.c.). A control group of dams (C dam) received 0.5% carboxymethylcellulose (CMC). A L-NAME-treated group received 1 mg/ml L-NAME dissolved in CMC. The L-NAME-treated dams were divided into 2 subgroups 13 d.p.c. One subgroup continued to receive L-NAME (L dams). The other subgroup received L-NAME with 0.08 mg/ml tadalafil suspended in CMC (TL dams). Maternal systolic blood pressure (SBP) and proteinuria were assessed 16 d.p.c. Fetal weight was recorded, and placentas and maternal kidneys were collected 17 d.p.c., Results: Maternal SBP, proteinuria, and fetal weight were improved for TL dams compared to L dams. The placental concentration of placental growth factor (PlGF) was higher for TL dams than for the C and L dams. The placental maternal blood sinuses of L dams were narrower than those of C dams, but those of TL dams improved to a similar width as C dams. Glomerular oxidative stress was ameliorated in TL dams compared to L dams., Conclusions: Tadalafil dilates the placental maternal blood sinuses, which leads to increase PlGF production, and contributes to facilitate fetal growth and improve maternal SBP. Moreover, tadalafil ameliorates glomerular damage by reducing oxidative stress. These results suggest that tadalafil is a candidate for treatment of PE with FGR., (© American Journal of Hypertension, Ltd 2017. All rights reserved. For Permissions, please email: journals.permissions@oup.com)
- Published
- 2017
- Full Text
- View/download PDF
225. Plastic deformation behaviour of single-crystalline martensite of Ti-Nb shape memory alloy.
- Author
-
Tahara M, Okano N, Inamura T, and Hosoda H
- Abstract
β-Ti alloys have attracted considerable attention as new biomedical shape memory alloys. Given the critical importance of the plastic deformation in the martensite phase for the shape memory effect and superelasticity, we investigated here the plastic deformation behaviour of a single crystal of α″ (orthorhombic) martensite of Ti-27 mol%Nb shape memory alloy obtained by the stress-induced martensitic transformation of a single crystal of the parent β phase. Four operative plastic deformation modes were observed, including two dislocation slips and two twinnings. To the best of our knowledge, two of these plastic deformation modes (one dislocation slip and one twinning) were discovered for the first time in this study. The identified slip and twinning systems in the martensite phase have corresponding slip and twinning systems in the parent β phase with which they share many similarities. Therefore, we believe that the plastic deformation of the α″ martensite is inherited from that of the parent β phase.
- Published
- 2017
- Full Text
- View/download PDF
226. Antimicrobial cathelicidin peptide LL‑37 induces NET formation and suppresses the inflammatory response in a mouse septic model.
- Author
-
Hosoda H, Nakamura K, Hu Z, Tamura H, Reich J, Kuwahara-Arai K, Iba T, Tabe Y, and Nagaoaka I
- Subjects
- Alarmins metabolism, Animals, Antimicrobial Cationic Peptides, Bacterial Load, Biomarkers, Cytokines metabolism, DNA metabolism, Disease Models, Animal, HMGB1 Protein metabolism, Histones metabolism, Leukocyte Count, Male, Mice, Peritoneal Cavity microbiology, Peritoneal Cavity pathology, Sepsis blood, Sepsis drug therapy, Triggering Receptor Expressed on Myeloid Cells-1 metabolism, Cathelicidins pharmacology, Extracellular Traps drug effects, Neutrophils drug effects, Neutrophils physiology, Sepsis etiology, Sepsis metabolism
- Abstract
LL‑37 is the only known member of the cathelicidin family of antimicrobial peptides in humans. In addition to its broad spectrum of antimicrobial activities, LL‑37 may modulate various inflammatory reactions. The authors previously revealed that LL‑37 improves the survival of a murine cecal ligation and puncture (CLP) sepsis model. In the present study, the mechanism for the protective action of LL‑37 was elucidated using the CLP model, focusing on the effect of LL‑37 on the release of neutrophil extracellular traps (NETs). The results indicated that the intravenous administration of LL‑37 suppressed the increase of damage-associated molecular patterns (DAMPs), including histone‑DNA complex and high‑mobility group protein 1, in addition to interleukin‑1β, tumor necrosis‑α and soluble triggering receptor expressed on myeloid cells (TREM)‑1 in plasma and peritoneal fluids. Notably, LL‑37 significantly suppressed the decrease of mononuclear cell number in blood, and the increase of polymorphonuclear cell (neutrophil) number in the peritoneal cavity during sepsis. Furthermore, LL‑37 reduced the bacterial burden in blood and peritoneal fluids. Notably, LL‑37 increased the level of NETs (myeloperoxidase‑DNA complex) in plasma and peritoneal fluids. In addition, it was verified that LL‑37 induces the release of NETs from neutrophils, and NETs possess the bactericidal activity. Overall, these observations suggest that LL‑37 improves the survival of CLP septic mice by possibly suppressing the inflammatory responses as evidenced by the inhibition of the increase of cytokines, soluble TREM‑1 and DAMPs (host cell death) and the alteration of inflammatory cell numbers, and bacterial growth via the release of NETs with bactericidal activity.
- Published
- 2017
- Full Text
- View/download PDF
227. Overexpression of C-type Natriuretic Peptide in Endothelial Cells Protects against Insulin Resistance and Inflammation during Diet-induced Obesity.
- Author
-
Bae CR, Hino J, Hosoda H, Arai Y, Son C, Makino H, Tokudome T, Tomita T, Kimura T, Nojiri T, Hosoda K, Miyazato M, and Kangawa K
- Subjects
- Adipocytes metabolism, Animals, Energy Metabolism, Glucose Intolerance, Guanylate Cyclase genetics, Guanylate Cyclase metabolism, Liver metabolism, Mice, Mice, Transgenic, Natriuretic Peptide, C-Type metabolism, Obesity metabolism, RNA, Messenger genetics, Thermogenesis genetics, Diet, High-Fat adverse effects, Endothelial Cells metabolism, Gene Expression, Inflammation genetics, Insulin Resistance genetics, Natriuretic Peptide, C-Type genetics, Obesity etiology
- Abstract
The endogenous peptide C-type natriuretic peptide (CNP) binds its receptor, guanylyl cyclase B (GCB), and is expressed by endothelial cells in diverse tissues. Because the endothelial cells of visceral adipose tissue have recently been reported to play a role in lipid metabolism and inflammation, we investigated the effects of CNP on features of obesity by using transgenic (Tg) mice in which CNP was placed under the control of the Tie2 promoter and was thus overexpressed in endothelial cells (E-CNP). Here we show that increased brown adipose tissue thermogenesis in E-CNP Tg mice increased energy expenditure, decreased mesenteric white adipose tissue (MesWAT) fat weight and adipocyte hypertrophy, and prevented the development of fatty liver. Furthermore, CNP overexpression improved glucose tolerance, decreased insulin resistance, and inhibited macrophage infiltration in MesWAT, thus suppressing pro-inflammation during high-fat diet-induced obesity. Our findings indicate an important role for the CNP produced by the endothelial cells in the regulation of MesWAT hypertrophy, insulin resistance, and inflammation during high-fat diet-induced obesity.
- Published
- 2017
- Full Text
- View/download PDF
228. Synchronized Collective Proton-Assisted Electron Transfer in Solid State by Hydrogen-Bonding Ru(II)/Ru(III) Mixed-Valence Molecular Crystals.
- Author
-
Tadokoro M, Hosoda H, Inoue T, Murayama A, Noguchi K, Iioka A, Nishimura R, Itoh M, Sugaya T, Kamebuchi H, and Haga MA
- Abstract
A proton-coupled electron transfer (PCET) reaction was widely studied with isolated organic molecules and metal complexes in solution in view of the biological catalytic reaction, while studying this reaction in the crystalline or solid-state phase, which has a novel example, would give insight into the rather internal environment of proteins without solvation and a creation of new molecular materials. We tried to crystallize a hydrogen-bonded (H-bonded) coordination polymer with one-dimensional nanoporous channels, formed from redox-active Ru
III complexes, [RuIII (Hbim)3 ] (Hbim- = 2,2'-biimidazolate monoanion). As a result, a synchronized collective PCET phenomenon was observed for the molecular nanoporous crystal by novel solid-state cyclic voltammetry (CV), which could be measured by only setting some crystals on the electrode surface. The nanoporous crystals, {[RuIII (Hbim)3 ]}n (1), are simultaneously induced to a synchronized collective RuII RuIII mixed-valence state, {RuII RuIII }n , with alternating arrays of RuII and RuIII complexes by PCET in a way of the reductive state of {RuII RuII }n . Further, a new crystal with {RuII RuIII }n , {[RuII (H2 bim)(Hbim)2 ][RuIII (bim) (Hbim)2 ][K(MeOBz)6 ]}n (2), was also prepared, and the solid-state CV revealed the same electrochemical behavior of {RuII RuIII }n with 1. The single crystal with {RuII RuIII }n of 2 was unusually a semiconductor with 5.12 × 10-6 S/cm conductivity at 298 K by an impedance method (8.01 × 10-6 S/cm by a direct-current method at 277 K). Thus, an unprecedented electron-hopping conductor driven by a low-barrier proton transfer through a PCET mechanism (Ea = 0.30 eV) was realized in the H-bonding molecular crystal with {RuII RuIII }n . Such studies on a PCET reaction in the crystalline state is not only worthwhile as a model of essential biological reactions without solvation, but also proposed to a new design of molecular materials to occur an electron transfer by using an intermolecular H-bond.- Published
- 2017
- Full Text
- View/download PDF
229. Evaluation of Natriuretic Peptide in Non-small Cell Lung Cancer Patients Treated with Bevacizumab Together with Carboplatin-Paclitaxel: A Prospective Study.
- Author
-
Otsuka T, Nojiri T, Minami S, Hosoda H, Kuroyama M, Hirata H, Nakanishi K, Yamamoto S, Komuta K, Kangawa K, and Kijima T
- Subjects
- Aged, Bevacizumab administration & dosage, Biomarkers, Tumor metabolism, Carboplatin administration & dosage, Carcinoma, Non-Small-Cell Lung mortality, Carcinoma, Non-Small-Cell Lung pathology, Disease Progression, Disease-Free Survival, Female, Humans, Lung Neoplasms mortality, Lung Neoplasms pathology, Male, Middle Aged, Paclitaxel administration & dosage, Plasma metabolism, Prospective Studies, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Carcinoma, Non-Small-Cell Lung drug therapy, Carcinoma, Non-Small-Cell Lung metabolism, Lung Neoplasms drug therapy, Lung Neoplasms metabolism, Natriuretic Peptides metabolism
- Abstract
Aim: To identify predictive markers for efficacy of combination bevacizumab and carboplatin-paclitaxel treatment in patients with advanced non-squamous non-small cell lung cancer (NSCLC)., Patients and Methods: Twenty patients received carboplatin (area under the concentration-time curve (AUC) 6 mg/ml×min) and paclitaxel (200 mg/m
2 ) with bevacizumab (15 mg/kg) on day 1 of a 21-day cycle. After four cycles of induction therapy, patients received bevacizumab maintenance therapy until disease progression or unacceptable toxicity occurred. Plasma and serum samples (baseline, day 8 and before cycle 2) were analyzed for natriuretic peptide content., Results: Plasma brain natriuretic peptide (BNP) levels were significantly decreased at day 8 (20.1±4.0 pg/ml vs. 9.1±1.8 pg/ml, p=0.0002). Patients whose plasma BNP level was reduced to <50% of the baseline at day 8 had a longer progression-free survival (PFS) than those with a less decrease (9.73 versus 2.63 months, p=0.00013). In multivariate Cox analysis, decrease of plasma BNP concentration was associated with a longer PFS (p=0.0022)., Conclusion: Decrease of plasma BNP concentration correlated with PFS after a treatment of combination bevacizumab plus carboplatin-paclitaxel., (Copyright© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.)- Published
- 2017
- Full Text
- View/download PDF
230. Transcriptome analysis reveals a role for the endothelial ANP-GC-A signaling in interfering with pre-metastatic niche formation by solid cancers.
- Author
-
Nojiri T, Arai M, Suzuki Y, Kumazoe M, Tokudome T, Miura K, Hino J, Hosoda H, Miyazato M, Okumura M, Kawaoka S, and Kangawa K
- Abstract
Cancer establishes a microenvironment called the pre-metastatic niche in distant organs where disseminated cancer cells can efficiently metastasize. Pre-metastatic niche formation requires various genetic factors. Previous studies suggest that inhibiting a single niche-factor is insufficient to completely block pre-metastatic niche formation especially in human patients. Here we show that the atrial natriuretic peptide (ANP), an endogenous hormone produced by the heart, inhibits pre-metastatic niche formation and metastasis of murine solid cancer models when pharmacologically supplied in vivo . On the basis of a wealth of comprehensive RNA-seq data, we demonstrated that ANP globally suppressed expression of cancer-induced genes including known niche-factors in the lung. The lungs of mice overexpressing GC-A, a receptor for ANP in endothelial cells, were conferred resistance against pre-metastatic niche formation. Importantly, neither ANP administration nor GC-A overexpression had a detrimental effect on lung gene expression in a cancer-free condition. The current study establishes endothelial ANP-GC-A signaling as a therapeutic target to control the pre-metastatic niche., Competing Interests: CONFLICTS OF INTEREST T. Nojiri, H. Hosoda, M. Okumura, and K. Kangawa have the filed patent related to ANP for the treatment of cancer metastasis with Shionogi & Co., Ltd., which has a part of the right to apply for the patent transferred from one of the original applicants, Daiichi-Sankyo Pharmaceutical Inc. (PCT/JP2012/054841). The other authors have no competing interests.
- Published
- 2017
- Full Text
- View/download PDF
231. CCM2 and PAK4 act downstream of atrial natriuretic peptide signaling to promote cell spreading.
- Author
-
Miura K, Nojiri T, Akitake Y, Ando K, Fukuhara S, Zenitani M, Kimura T, Hino J, Miyazato M, Hosoda H, and Kangawa K
- Subjects
- Animals, Carrier Proteins antagonists & inhibitors, Carrier Proteins genetics, Carrier Proteins metabolism, Cattle, Cell Movement, Cells, Cultured, Endothelium, Vascular cytology, Endothelium, Vascular enzymology, Enzyme Activation, HEK293 Cells, Humans, Luminescent Proteins genetics, Luminescent Proteins metabolism, Mice, Mutation, Myosin Light Chains metabolism, Phosphorylation, Protein Interaction Domains and Motifs, Protein Processing, Post-Translational, Protein Transport, RNA Interference, Receptors, Atrial Natriuretic Factor chemistry, Receptors, Atrial Natriuretic Factor metabolism, Recombinant Fusion Proteins chemistry, Recombinant Fusion Proteins metabolism, p21-Activated Kinases antagonists & inhibitors, p21-Activated Kinases chemistry, p21-Activated Kinases genetics, Actin Cytoskeleton metabolism, Atrial Natriuretic Factor metabolism, Carrier Proteins agonists, Endothelium, Vascular metabolism, Receptors, Atrial Natriuretic Factor agonists, Signal Transduction, p21-Activated Kinases metabolism
- Abstract
Atrial natriuretic peptide (ANP) is a cardiac hormone released by the atrium in response to stretching forces. Via its receptor, guanylyl cyclase-A (GC-A), ANP maintains cardiovascular homeostasis by exerting diuretic, natriuretic, and hypotensive effects mediated, in part, by endothelial cells. Both in vivo and in vitro , ANP enhances endothelial barrier function by reducing RhoA activity and reorganizing the actin cytoskeleton. We established mouse endothelial cells that stably express GC-A and used them to analyze the molecular mechanisms responsible for actin reorganization. Stimulation by ANP resulted in phosphorylation of myosin light chain (MLC) and promotion of cell spreading. p21-activated kinase 4 (PAK4) and cerebral cavernous malformations 2 (CCM2), a scaffold protein involved in a cerebrovascular disease, were required for the phosphorylation of MLC and promotion of cell spreading by ANP. Finally, in addition to the GC domain, the kinase homology domain of GC-A was also required for ANP/GC-A signaling. Our results indicate that CCM2 and PAK4 are important downstream mediators of ANP/GC-A signaling involved in cell spreading, an important initial step in the enhancement of endothelial barrier function., (© 2017 The Author(s); published by Portland Press Limited on behalf of the Biochemical Society.)
- Published
- 2017
- Full Text
- View/download PDF
232. Myeloprotective effects of C-type natriuretic peptide on cisplatin-induced bone marrow granulocytopenia in mice.
- Author
-
Zenitani M, Nojiri T, Kimura T, Hosoda H, Miura K, Hino J, Nakahata K, Uehara S, Miyazato M, Oue T, Okuyama H, and Kangawa K
- Subjects
- Animals, Chemokine CXCL12 genetics, Mice, Mice, Inbred C57BL, Protective Agents pharmacology, RNA, Messenger analysis, Receptors, CXCR4 genetics, Agranulocytosis prevention & control, Bone Marrow drug effects, Cisplatin toxicity, Natriuretic Peptide, C-Type pharmacology
- Abstract
Purpose: Cisplatin is an effective chemotherapeutic agent used to treat a variety of malignant tumors. The major toxicity associated with cisplatin treatment is granulocytopenia. C-type natriuretic peptide (CNP), a member of the natriuretic peptide family, protects against toxicity in many organs, including the heart, blood vessels, lung, and kidney. The objective of this study was to investigate the myeloprotective effects of CNP in a mouse model of cisplatin-induced granulocytopenia., Methods: The mice were divided into two groups: cisplatin with vehicle and cisplatin with CNP. CNP (2.5 μg/kg/min via osmotic pump, subcutaneously) or vehicle administration was started two day before cisplatin injection, and continued until the mice were killed. At 0, 2, 4, 8, and 14 days after cisplatin injection (16 mg/kg, intraperitoneally as a single dose), we counted total and living cells and granulocyte/macrophage colony-forming units (CFU-GM) in bone marrow. In addition, at 0, 1, 2, and 4 days after cisplatin injection, we measured mRNA levels of CXC chemokine receptor 4 (CXCR4) and chemokine CXC ligand 12 (CXCL12) in bone marrow., Results: CNP significantly attenuated the reduction in bone marrow nucleated cell count and CFU-GM in bone marrow at 4 days after cisplatin injection. Four days after cisplatin injection, CNP significantly decreased the CXCR4 mRNA level in bone marrow, but had no effect on the level of CXCL12 mRNA., Conclusions: CNP exerts myeloprotective effects in cisplatin-induced granulocytopenia and decreases CXCR4 expression.
- Published
- 2017
- Full Text
- View/download PDF
233. Atrial natriuretic peptide protects against bleomycin-induced pulmonary fibrosis via vascular endothelial cells in mice : ANP for pulmonary fibrosis.
- Author
-
Okamoto A, Nojiri T, Konishi K, Tokudome T, Miura K, Hosoda H, Hino J, Miyazato M, Kyomoto Y, Asai K, Hirata K, and Kangawa K
- Subjects
- Animals, Bleomycin, Endothelial Cells drug effects, Endothelial Cells pathology, Immunologic Factors immunology, Lung drug effects, Lung pathology, Male, Mice, Mice, Inbred C57BL, Pulmonary Fibrosis pathology, Treatment Outcome, Atrial Natriuretic Factor administration & dosage, Endothelial Cells immunology, Lung immunology, Pulmonary Fibrosis drug therapy, Pulmonary Fibrosis immunology
- Abstract
Background: Pulmonary fibrosis is a life-threatening disease characterized by progressive dyspnea and worsening pulmonary function. Atrial natriuretic peptide (ANP), a heart-derived secretory peptide used clinically in Japan for the treatment of acute heart failure, exerts a wide range of protective effects on various organs, including the heart, blood vessels, kidneys, and lungs. Its therapeutic properties are characterized by anti-inflammatory and anti-fibrotic activities mediated by the guanylyl cyclase-A (GC-A) receptor. We hypothesized that ANP would have anti-fibrotic and anti-inflammatory effects on bleomycin (BLM)-induced pulmonary fibrosis in mice., Methods: Mice were divided into three groups: normal control, BLM with vehicle, and BLM with ANP. ANP (0.5 μg/kg/min via osmotic-pump, subcutaneously) or vehicle administration was started before BLM administration (1 mg/kg) and continued until the mice were sacrificed. At 7 or 21 days after BLM administration, fibrotic changes and infiltration of inflammatory cells in the lungs were assessed based on histological findings and analysis of bronchoalveolar lavage fluid. In addition, fibrosis and inflammation induced by BLM were evaluated in vascular endothelium-specific GC-A overexpressed mice. Finally, attenuation of transforming growth factor-β (TGF-β) signaling by ANP was studied using immortalized mouse endothelial cells stably expressing GC-A receptor., Results: ANP significantly decreased lung fibrotic area and infiltration of inflammatory cells in lungs after BLM administration. Furthermore, similar effects of ANP were observed in vascular endothelium-specific GC-A overexpressed mice. In cultured mouse endothelial cells, ANP reduced phosphorylation of Smad2 after TGF-β stimulation., Conclusions: ANP exerts protective effects on BLM-induced pulmonary fibrosis via vascular endothelial cells.
- Published
- 2017
- Full Text
- View/download PDF
234. Therapeutic potential of ghrelin and des-acyl ghrelin against chemotherapy-induced cardiotoxicity.
- Author
-
Nonaka M, Kurebayashi N, Murayama T, Sugihara M, Terawaki K, Shiraishi S, Miyano K, Hosoda H, Kishida S, Kangawa K, Sakurai T, and Uezono Y
- Subjects
- Animals, Antineoplastic Agents therapeutic use, Cardiotoxicity diagnostic imaging, Cell Survival drug effects, Doxorubicin therapeutic use, Echocardiography, Ghrelin administration & dosage, Heart diagnostic imaging, Mice, Myocytes, Cardiac drug effects, Protective Agents administration & dosage, Antineoplastic Agents adverse effects, Cardiotoxicity drug therapy, Doxorubicin adverse effects, Ghrelin therapeutic use, Heart drug effects, Protective Agents therapeutic use
- Abstract
Cancer was considered an incurable disease for many years; however, with the development of anticancer drugs and state-of-the art technologies, it has become curable. Cardiovascular diseases in patients with cancer or induced by cancer chemotherapy have recently become a great concern. Certain anticancer drugs and molecular targeted therapies cause cardiotoxicity, which limit the widespread implementation of cancer treatment and decrease the quality of life in cancer patients significantly. The anthracycline doxorubicin (DOX) causes cardiotoxicity. The cellular mechanism underlying DOX-induced cardiotoxicity include free-radical damage to cardiac myocytes, leading to mitochondrial injury and subsequent death of myocytes. Recently, circulating orexigenic hormones, ghrelin and des-acyl ghrelin, have been reported to inhibit DOX-induced cardiotoxicity. However, little is known about the molecular mechanisms underlying their preventive effects. In the present study, we show the possible mechanisms underlying the effects of ghrelin and des-acyl ghrelin against DOX-induced cardiotoxicity through in vitro and in vivo researches.
- Published
- 2017
- Full Text
- View/download PDF
235. Effect of basal insulin therapy on vascular endothelial function and adipokine profiles in people with Type 2 diabetes.
- Author
-
Makino H, Tanaka A, Hosoda H, Koezuka R, Tochiya M, Ohata Y, Tamanaha T, Miyamoto Y, Kangawa K, and Kishimoto I
- Subjects
- Adiponectin metabolism, Adult, Aged, Ankle Brachial Index, C-Reactive Protein metabolism, Cross-Over Studies, Diabetes Mellitus, Type 2 complications, Endothelium, Vascular drug effects, Female, Ghrelin metabolism, Humans, Leptin metabolism, Male, Middle Aged, Obesity complications, Plasminogen Activator Inhibitor 1 metabolism, Vasodilation drug effects, Young Adult, Adipokines metabolism, Diabetes Mellitus, Type 2 drug therapy, Endothelium, Vascular physiology, Hypoglycemic Agents therapeutic use, Insulin Detemir therapeutic use, Insulin Glargine therapeutic use
- Abstract
Aim: To compare the effects of the basal insulin analogues glargine and detemir on endothelial function and adipocytokine levels in people with Type 2 diabetes., Methods: We studied 32 people with Type 2 diabetes whose blood glucose control was unsatisfactory while receiving only oral hypoglycaemic drugs. Participants were randomized to either insulin glargine or detemir for 24 weeks and then crossed over to the other treatment without a washout period. Flow-mediated vasodilatation, adipocytokine levels (plasminogen activator inhibitor-1 and leptin/adiponectin ratio), and fasting ghrelin levels were monitored., Results: HbA
1c levels were significantly decreased by both basal insulin therapies. Body weight was significantly increased by glargine but not by detemir. The proportion of flow-mediated vasodilatation was significantly increased by detemir but not glargine (glargine: from 5.17 ± 0.69 to 5.94 ± 0.83%; detemir: from 4.89 ± 0.78 to 7.92 ± 0.69%). Plasminogen activator inhibitor-1 level was significantly decreased by only detemir (glargine: from 16.4 ± 1.8 to 17.3 ± 2.1; detemir: from 19.2 ± 2.8 to 16.0 ± 1.6 ng/ml). The leptin/adiponectin ratio was significantly increased only by glargine. Acyl ghrelin level was significantly decreased by glargine but not detemir., Conclusions: These results suggest that the effect on endothelial function and adipocytokine profiles may differ between glargine and detemir in people with diabetes (Trial registration ID: UMIN000004973)., (© 2016 Diabetes UK.)- Published
- 2016
- Full Text
- View/download PDF
236. Erratum to: C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice.
- Author
-
Kimura T, Nojiri T, Hino J, Hosoda H, Miura K, Shintani Y, Inoue M, Zenitani M, Takabatake H, Miyazato M, Okumura M, and Kangawa K
- Published
- 2016
- Full Text
- View/download PDF
237. RETRACTED: Protective effects of ghrelin on cisplatin-induced nephrotoxicity in mice.
- Author
-
Nojiri T, Hosoda H, Kimura T, Tokudome T, Miura K, Takabatake H, Miyazato M, Okumura M, and Kangawa K
- Subjects
- Acute Kidney Injury blood, Acute Kidney Injury chemically induced, Acute Kidney Injury metabolism, Animals, Apoptosis drug effects, Blood Urea Nitrogen, Chemokine CCL2 genetics, Cisplatin adverse effects, Gene Expression Regulation, Humans, Interleukin-6 genetics, Kidney metabolism, Kidney pathology, Mice, Neoplasms drug therapy, Tumor Necrosis Factor-alpha genetics, Acute Kidney Injury drug therapy, Ghrelin administration & dosage, Kidney drug effects, Neoplasms complications
- Abstract
This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy). This article has been retracted at the request of the Authors. The Authors express that: although main outcome is correct, there are some errors in calculation, statistical analysis, description for sample numbers and data preparation including, using the common control and vehicle group already reported in the other paper. Those experiments were performed at the same time but, we lacked explanation for those condition (Cancer Chemother Pharmacol. 2015;75:123-9). Taken together, we decided to retract this article due to those errors., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
238. Atrial natriuretic peptide protects against cisplatin-induced granulocytopenia.
- Author
-
Nojiri T, Hosoda H, Zenitani M, Tokudome T, Kimura T, Miura K, Miyazato M, Okumura M, and Kangawa K
- Subjects
- Agranulocytosis chemically induced, Animals, Atrial Natriuretic Factor pharmacology, Granulocyte-Macrophage Progenitor Cells metabolism, Leukocyte Count, Mice, Mice, Inbred C57BL, Time Factors, Agranulocytosis prevention & control, Antineoplastic Agents toxicity, Atrial Natriuretic Factor administration & dosage, Cisplatin toxicity, Granulocyte Colony-Stimulating Factor blood
- Abstract
Purpose: Granulocytopenia is the major toxicity associated with cisplatin treatment. Atrial natriuretic peptide (ANP) is a cardiac hormone used clinically for the treatment of acute heart failure in Japan. ANP exerts a wide range of protective effects on various organs, including the heart, blood vessels, lungs, and kidneys. This study's objective was to investigate the protective effects of ANP on cisplatin-induced granulocytopenia in mice., Methods: The mice were divided into two groups: cisplatin with vehicle and cisplatin with ANP. ANP (1.5 μg/kg/min via osmotic pump, subcutaneously) or vehicle administration was started 1 day before cisplatin injection until the mice were killed. At 0, 2, 4, 8, and 14 days after cisplatin injection (16 mg/kg, intraperitoneally as a single dose), the white blood cell, red blood cell, and platelet counts were measured in the peripheral blood in both groups. The numbers of total and live cells and colony-forming unit-granulocyte-macrophage (CFU-GM) colonies in the bone marrow of the mice were also examined. In addition, at 0, 0.5, 1, and 2 days after cisplatin injection, serum granulocyte colony-stimulating factor (G-CSF) levels were measured., Results: ANP significantly attenuated the white blood cell count decrease in the peripheral blood 2 and 4 days after cisplatin injection. ANP also attenuated the decrease in the number of live cells and CFU-GM colonies in bone marrow 2, 4, and 8 days after cisplatin injection. ANP significantly increased serum G-CSF levels 1 day after cisplatin injection., Conclusions: ANP has protective effects in cisplatin-induced granulocytopenia, with increased G-CSF production.
- Published
- 2016
- Full Text
- View/download PDF
239. Improvement of cisplatin-related renal dysfunction by synthetic ghrelin: a prospective randomised phase II trial.
- Author
-
Yanagimoto Y, Takiguchi S, Miyazaki Y, Makino T, Takahashi T, Kurokawa Y, Yamasaki M, Miyata H, Nakajima K, Hosoda H, Kangawa K, Mori M, and Doki Y
- Subjects
- Aged, Antineoplastic Combined Chemotherapy Protocols adverse effects, Antineoplastic Combined Chemotherapy Protocols therapeutic use, Carcinoma, Squamous Cell drug therapy, Carcinoma, Squamous Cell metabolism, Cisplatin administration & dosage, Creatinine blood, Drug Interactions, Esophageal Neoplasms drug therapy, Esophageal Neoplasms metabolism, Esophageal Squamous Cell Carcinoma, Female, Humans, Insulin-Like Growth Factor I metabolism, Kidney drug effects, Kidney metabolism, Kidney Diseases blood, Male, Prospective Studies, Cisplatin adverse effects, Ghrelin therapeutic use, Kidney Diseases chemically induced, Kidney Diseases prevention & control
- Abstract
Background: Ghrelin, a 28-amino acid peptide predominantly produced by the stomach, exerts powerful renal protective effects by increasing levels of insulin-like growth factor-1 (IGF-1). The aim of this study was to evaluate the effects of ghrelin on the incidence of renal dysfunction in patients receiving cisplatin-based chemotherapy., Methods: Forty patients with oesophageal cancer receiving cisplatin-based chemotherapy were assigned to either the ghrelin group (n=20), which received ghrelin (0.5 μg kg(-1) h(-1)) for 5 days, or a placebo group (n=20). The primary endpoint was serum creatinine. Secondary endpoints were serum cystatin C, chemotherapy-related adverse events, changes in serum ghrelin-related hormone levels, correlation between markers of renal injury and hormone concentrations, and effects on the second cycle of chemotherapy., Results: Blood acyl ghrelin, total ghrelin, and IGF-1 concentrations on day 4 were significantly higher in the ghrelin group. The renal dysfunction, serum creatinine and cystatin C levels, dose reduction, and delay in the initiation of the second cycle of chemotherapy were lower in the ghrelin group than in the control group. Serum creatinine levels were significantly correlated with serum IGF-1 levels., Conclusion: Continuous synthetic ghrelin administration during cisplatin-based chemotherapy attenuated renal dysfunction and harmful effects on subsequent chemotherapy, possibly by increasing IGF-1 levels.
- Published
- 2016
- Full Text
- View/download PDF
240. C-type natriuretic peptide in combination with sildenafil attenuates proliferation of rhabdomyosarcoma cells.
- Author
-
Zenitani M, Nojiri T, Uehara S, Miura K, Hosoda H, Kimura T, Nakahata K, Miyazato M, Okuyama H, and Kangawa K
- Subjects
- Adolescent, Animals, Cell Proliferation drug effects, Child, Child, Preschool, Dose-Response Relationship, Drug, Drug Synergism, Female, Humans, Infant, MAP Kinase Signaling System drug effects, Male, Mice, Inbred BALB C, Natriuretic Peptide, C-Type administration & dosage, Phosphorylation drug effects, Receptors, Atrial Natriuretic Factor metabolism, Rhabdomyosarcoma enzymology, Sildenafil Citrate administration & dosage, Tumor Cells, Cultured, Up-Regulation, Xenograft Model Antitumor Assays methods, Antineoplastic Combined Chemotherapy Protocols pharmacology, Rhabdomyosarcoma pathology
- Abstract
Rhabdomyosarcoma (RMS) is a malignant mesenchymal tumor and the most common soft tissue sarcoma in children. Because of several complications associated with intensive multimodal therapies, including growth disturbance and secondary cancer, novel therapies with less toxicity are urgently needed. C-type natriuretic peptide (CNP), an endogenous peptide secreted by endothelial cells, exerts antiproliferative effects in multiple types of mesenchymal cells. Therefore, we investigated whether CNP attenuates proliferation of RMS cells. We examined RMS patient samples and RMS cell lines. All RMS clinical samples expressed higher levels of guanylyl cyclase B (GC-B), the specific receptor for CNP, than RMS cell lines. GC-B expression in RMS cells decreased with the number of passages in vitro. Therefore, GC-B stable expression lines were established to mimic clinical samples. CNP increased cyclic guanosine monophosphate (cGMP) levels in RMS cells in a dose-dependent manner, demonstrating the biological activity of CNP. However, because cGMP is quickly degraded by phosphodiesterases (PDEs), the selective PDE5 inhibitor sildenafil was added to inhibit its degradation. In vitro, CNP, and sildenafil synergistically inhibited proliferation of RMS cells stably expressing GC-B and decreased Raf-1, Mitogen-activated protein kinase kinase (MEK), and extracellular signal-regulated kinase (ERK) phosphorylation. These results suggested that CNP in combination with sildenafil exerts antiproliferative effects on RMS cells by inhibiting the Raf/MEK/ERK pathway. This regimen exerted synergistic effects on tumor growth inhibition without severe adverse effects in vivo such as body weight loss. Thus, CNP in combination with sildenafil represents a promising new therapeutic approach against RMS., (© 2016 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.)
- Published
- 2016
- Full Text
- View/download PDF
241. High incorporation of long-chain fatty acids contributes to the efficient production of acylated ghrelin in ghrelin-producing cells.
- Author
-
Bando M, Iwakura H, Koyama H, Hosoda H, Shigematsu Y, Ariyasu H, Akamizu T, Kangawa K, and Nakao K
- Subjects
- Acylation, Acyltransferases antagonists & inhibitors, Acyltransferases genetics, Animals, Carnitine analogs & derivatives, Carnitine metabolism, Cell Line, Coenzyme A Ligases antagonists & inhibitors, Coenzyme A Ligases genetics, Enteroendocrine Cells cytology, Enteroendocrine Cells drug effects, Enzyme Inhibitors pharmacology, Fatty Acids, Nonesterified chemistry, Gene Expression Profiling, Gene Expression Regulation drug effects, Insulin-Secreting Cells cytology, Insulin-Secreting Cells drug effects, Insulin-Secreting Cells metabolism, Lipoylation, Membrane Proteins, Mice, Transgenic, Molecular Weight, RNA Interference, Recombinant Fusion Proteins, Triazenes pharmacology, Acyltransferases metabolism, Coenzyme A Ligases metabolism, Enteroendocrine Cells metabolism, Fatty Acids, Nonesterified metabolism, Ghrelin metabolism, Protein Processing, Post-Translational drug effects
- Abstract
The mechanisms for supplying octanoic acid for ghrelin acylation in X/A-like cells are incompletely understood. We found that long-chain fatty acids were incorporated at a higher rate in the ghrelin-producing cell line MGN3-1 than in MIN6 cells, in part due to higher expression level of long-chain fatty acyl-CoA synthetase family member 1 (Acsl1). Inhibition of ACSLs by triacsin C profoundly suppressed acylated ghrelin production. These results suggest that high incorporation of long-chain fatty acids into the ghrelin-producing cells plays a role in the supply of octanoic acid for ghrelin acylation., (© 2016 Federation of European Biochemical Societies.)
- Published
- 2016
- Full Text
- View/download PDF
242. Optimum rolling ratio for obtaining {001}<110> recrystallization texture in Ti-Nb-Al biomedical shape memory alloy.
- Author
-
Inamura T, Shimizu R, Kim HY, Miyazaki S, and Hosoda H
- Subjects
- Dental Alloys chemistry
- Abstract
The rolling rate (r) dependence of textures was investigated in the Ti-26Nb-3Al (mol%) alloy to reveal the conditions required to form the {001}<110> recrystallization texture, which is a desirable orientation for the β-titanium shape memory alloy. {001}<110> was the dominant cold-rolling texture when r=90% and it was transferred to the recrystallization texture without forming {112}<110>, which is detrimental for the isotropic mechanical properties of the rolled sheet. A further increase in r resulted in the formation of {112}<110> in both rolling and recrystallization textures. Therefore, r should be controlled to form only the {001}<110> rolling texture, because the {112}<110> texture can overwhelm the {001}<110> texture during recrystallization., (Copyright © 2016 Elsevier B.V. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
243. Crystal structures of bis-[2-(pyridin-2-yl)phenyl-κ(2) N,C (1)]rhodium(III) complexes containing an aceto-nitrile or monodentate thyminate(1-) ligand.
- Author
-
Sakate M, Hosoda H, and Suzuki T
- Abstract
The crystal structures of bis-[2-(pyridin-2-yl)phen-yl]rhodium(III) complexes with the metal in an octahedral coordination containing chloride and aceto-nitrile ligands, namely (OC-6-42)-aceto-nitrile-chlorido-bis-[2-(pyridin-2-yl)phenyl-κ(2) N,C (1)]rhodium(III), [RhCl(C11H8N)2(CH3CN)] (1), thyminate(1-) and methanol, namely (OC-6-42)-methanol(5-methyl-2,4-dioxo-1,2,3,4-tetrahydro-pyrimidin-1-ido-κN (1))bis-[2-(pyridin-2-yl)phenyl-κ(2) N,C (1)]rhodium(III), [Rh(C11H8N)2(C5H5N2O2)(CH3OH)]·CH3OH·0.5H2O (2), and thy-min-ate(1-) and ethanol, namely (OC-6-42)-ethanol(5-methyl-2,4-dioxo-1,2,3,4-tetra-hydro-pyrimidin-1-ido-κN (1))bis[2-(pyridin-2-yl)phenyl-κ(2) N,C (1)]rhodium(III), [Rh(C11H8N)2(C5H5N2O2)(C2H5OH)]·C2H5OH (3), are reported. The aceto-nitrile complex, 1, is isostructural with the Ir(III) analog. In complexes 2 and 3, the monodeprotonated thyminate (Hthym(-)) ligand coordinates to the Rh(III) atom through the N atom, and the resulting Rh-N(Hthym) bond lengths are relatively long [2.261 (2) and 2.252 (2) Å for 2 and 3, respectively] as compared to the Rh-N bonds in the related thyminate complexes. In each of the crystals of 2 and 3, the complexes are linked via a pair of inter-molecular N-H⋯O hydrogen bonds between neighbouring Hthym(-) ligands, forming an inversion dimer. A strong intra-molecular O-H⋯O hydrogen bond between the thyminate(1-) and alcohol ligands in mutually cis positions to each other is also observed.
- Published
- 2016
- Full Text
- View/download PDF
244. Impact of synthetic ghrelin administration for patients with severe body weight reduction more than 1 year after gastrectomy: a phase II clinical trial.
- Author
-
Takiguchi S, Miyazaki Y, Takahashi T, Kurokawa Y, Yamasaki M, Nakajima K, Miyata H, Hosoda H, Kangawa K, Mori M, and Doki Y
- Subjects
- Aged, Aged, 80 and over, Appetite drug effects, Body Weight drug effects, Eating drug effects, Female, Ghrelin pharmacology, Humans, Male, Middle Aged, Observational Studies as Topic, Prospective Studies, Severity of Illness Index, Stimulation, Chemical, Time Factors, Treatment Outcome, Feeding and Eating Disorders drug therapy, Gastrectomy, Ghrelin administration & dosage, Postoperative Complications drug therapy, Weight Loss
- Abstract
Purpose: Ghrelin is mainly secreted from the stomach and plays a role in appetite, weight gain, and the promotion of a positive energy balance. The levels of ghrelin decrease immediately after gastrectomy. We herein investigated the effect of the administration of synthetic ghrelin to treat postoperative severe weight loss in a prospective, one-arm clinical trial to develop new strategies for weight gain., Methods: Ten patients (four distal gastrectomy and six total gastrectomy) received ghrelin treatment. Eligibility criteria included patients who underwent gastrectomy more than 1 year previously and 15 % body weight loss from the preoperative weight or a body mass index under 19. Synthetic human ghrelin (3 μg/kg) was administered to the patients twice a day for 1 week. Oral intake of calories, appetite [evaluated using the visual analog scale (VAS)], and body weight before and during administration of ghrelin were compared., Results: There was a significant difference in the oral food intake before and during treatment (before treatment: 1236 ± 409 kcal vs. during treatment: 1398 ± 365 kcal, p = 0.039), and the VAS for appetite significantly improved with each day of ghrelin administration (p < 0.05). Significant amounts of body weight were gained (39.5 ± 6.8 vs. 40.1 ± 6.9, p = 0.037)., Conclusions: The administration of synthetic ghrelin improved the food intake and was effective for treating appetite loss and body weight loss. Synthetic ghrelin may be a promising new therapy for severe body weight loss following gastrectomy.
- Published
- 2016
- Full Text
- View/download PDF
245. C-type natriuretic peptide ameliorates pulmonary fibrosis by acting on lung fibroblasts in mice.
- Author
-
Kimura T, Nojiri T, Hino J, Hosoda H, Miura K, Shintani Y, Inoue M, Zenitani M, Takabatake H, Miyazato M, Okumura M, and Kangawa K
- Subjects
- Animals, Cells, Cultured, Fibroblasts drug effects, Lung drug effects, Lung immunology, Lung pathology, Male, Mice, Mice, Transgenic, Natriuretic Peptide, C-Type pharmacology, Pulmonary Fibrosis pathology, Treatment Outcome, Cytokines immunology, Fibroblasts immunology, Fibroblasts pathology, Natriuretic Peptide, C-Type administration & dosage, Pulmonary Fibrosis drug therapy, Pulmonary Fibrosis immunology
- Abstract
Background: Pulmonary fibrosis has high rates of mortality and morbidity; however, no effective pharmacological therapy has been established. C-type natriuretic peptide (CNP), a member of the natriuretic peptide family, selectively binds to the transmembrane guanylyl cyclase (GC)-B receptor and exerts anti-inflammatory and anti-fibrotic effects in various organs through vascular endothelial cells and fibroblasts that have a cell-surface GC-B receptor. Given the pathophysiological importance of fibroblast activation in pulmonary fibrosis, we hypothesized that the anti-fibrotic and anti-inflammatory effects of exogenous CNP against bleomycin (BLM)-induced pulmonary fibrosis were exerted in part by the effect of CNP on pulmonary fibroblasts., Methods: C57BL/6 mice were divided into two groups, CNP-treated (2.5 μg/kg/min) and vehicle, to evaluate BLM-induced (1 mg/kg) pulmonary fibrosis and inflammation. A periostin-CNP transgenic mouse model exhibiting CNP overexpression in fibroblasts was generated and examined for the anti-inflammatory and anti-fibrotic effects of CNP via fibroblasts in vivo. Additionally, we assessed CNP attenuation of TGF-β-induced differentiation into myofibroblasts by using immortalized human lung fibroblasts stably expressing GC-B receptors. Furthermore, to investigate whether CNP acts on human lung fibroblasts in a clinical setting, we obtained primary-cultured fibroblasts from surgically resected lungs of patients with lung cancer and analyzed levels of GC-B mRNA transcription., Results: CNP reduced mRNA levels of the profibrotic cytokines interleukin (IL)-1β and IL-6, as well as collagen deposition and the fibrotic area in lungs of mice with bleomycin-induced pulmonary fibrosis. Furthermore, similar CNP effects were observed in transgenic mice exhibiting fibroblast-specific CNP overexpression. In cultured-lung fibroblasts, CNP treatment attenuated TGF-β-induced phosphorylation of Smad2 and increased mRNA and protein expression of α-smooth muscle actin and SM22α, indicating that CNP suppresses fibroblast differentiation into myofibroblasts. Furthermore, human lung fibroblasts from patients with or without interstitial lung disease substantially expressed GC-B receptor mRNA., Conclusions: These data suggest that CNP ameliorates bleomycin-induced pulmonary fibrosis by suppressing TGF-β signaling and myofibroblastic differentiation in lung fibroblasts. Therefore, we propose consideration of CNP for clinical application to pulmonary fibrosis treatment.
- Published
- 2016
- Full Text
- View/download PDF
246. Comprehensive Profiling of GPCR Expression in Ghrelin-Producing Cells.
- Author
-
Koyama H, Iwakura H, Dote K, Bando M, Hosoda H, Ariyasu H, Kusakabe T, Son C, Hosoda K, Akamizu T, Kangawa K, and Nakao K
- Subjects
- Adrenergic beta-Agonists pharmacology, Animals, Cell Line, Tumor, Colforsin pharmacology, Dinoprostone pharmacology, Gastric Mucosa cytology, Gastric Mucosa drug effects, Gene Expression Profiling, Ghrelin drug effects, Hormones pharmacology, Immunohistochemistry, Isoproterenol pharmacology, Lactic Acid pharmacology, Mice, Mice, Transgenic, Muscarine pharmacology, Muscarinic Agonists pharmacology, Oxytocics pharmacology, Oxytocin pharmacology, Palmitates pharmacology, Receptor, Muscarinic M4 agonists, Receptors, Adrenergic, beta-1 drug effects, Receptors, Adrenergic, beta-1 genetics, Receptors, Adrenergic, beta-1 metabolism, Receptors, G-Protein-Coupled drug effects, Receptors, G-Protein-Coupled metabolism, Receptors, Oxytocin drug effects, Receptors, Oxytocin genetics, Receptors, Oxytocin metabolism, Receptors, Prostaglandin E, EP4 Subtype agonists, Receptors, Somatostatin drug effects, Receptors, Somatostatin genetics, Receptors, Somatostatin metabolism, Sequence Analysis, RNA, Somatostatin pharmacology, Tryptophan pharmacology, Gastric Mucosa metabolism, Ghrelin metabolism, RNA, Messenger metabolism, Receptors, G-Protein-Coupled genetics
- Abstract
To determine the comprehensive G protein-coupled receptor (GPCR) expression profile in ghrelin-producing cells and to elucidate the role of GPCR-mediated signaling in the regulation of ghrelin secretion, we determined GPCR expression profiles by RNA sequencing in the ghrelin-producing cell line MGN3-1 and analyzed the effects of ligands for highly expressed receptors on intracellular signaling and ghrelin secretion. Expression of selected GPCRs was confirmed in fluorescence-activated cell-sorted fluorescently tagged ghrelin-producing cells from ghrelin-promoter CreERT2/Rosa-CAG-LSL-ZsGreen1 mice. Expression levels of GPCRs previously suggested to regulate ghrelin secretion including adrenergic-β1 receptor, GPR81, oxytocin receptor, GPR120, and somatostatin receptor 2 were high in MGN3-1 cells. Consistent with previous reports, isoproterenol and oxytocin stimulated the Gs and Gq pathways, respectively, whereas lactate, palmitate, and somatostatin stimulated the Gi pathway, confirming the reliability of current assays. Among other highly expressed GPCRs, prostaglandin E receptor 4 agonist prostaglandin E2 significantly stimulated the Gs pathway and ghrelin secretion. Muscarine, the canonical agonist of cholinergic receptor muscarinic 4, stimulated both the Gq and Gi pathways. Although muscarine treatment alone did not affect ghrelin secretion, it did suppress forskolin-induced ghrelin secretion, suggesting that the cholinergic pathway may play a role in counterbalancing the stimulation of ghrelin by Gs (eg, by adrenaline). In addition, GPR142 ligand tryptophan stimulated ghrelin secretion. In conclusion, we determined the comprehensive expression profile of GPCRs in ghrelin-producing cells and identified two novel ghrelin regulators, prostaglandin E2 and tryptophan. These results will lead to a greater understanding of the physiology of ghrelin and facilitate the development of ghrelin-modulating drugs.
- Published
- 2016
- Full Text
- View/download PDF
247. Association of baseline plasma des-acyl ghrelin level with the response to rikkunshito in patients with functional dyspepsia.
- Author
-
Togawa K, Matsuzaki J, Kobayakawa M, Fukushima Y, Suzaki F, Kasugai K, Nishizawa T, Naito Y, Hayakawa T, Kamiya T, Andoh T, Yoshida H, Tokura Y, Nagata H, Mori M, Kato K, Hosoda H, Takebayashi T, Miura S, Uemura N, Joh T, Hibi T, and Suzuki H
- Subjects
- Adult, Aged, Alcohol Drinking adverse effects, Biomarkers blood, Double-Blind Method, Drugs, Chinese Herbal administration & dosage, Female, Helicobacter Infections, Helicobacter pylori, Humans, Male, Middle Aged, Multicenter Studies as Topic, Randomized Controlled Trials as Topic, Severity of Illness Index, Treatment Outcome, Drugs, Chinese Herbal therapeutic use, Dyspepsia diagnosis, Dyspepsia drug therapy, Ghrelin blood, Outcome and Process Assessment, Health Care, Phytotherapy
- Abstract
Background and Aim: We recently conducted a randomized placebo-controlled trial on the efficacy and safety of rikkunshito, a standardized Japanese herbal medicine, for the treatment of functional dyspepsia (FD). The present post-hoc study aimed to evaluate the differences in clinical characteristics between responders and non-responders among FD patients who received rikkunshito for 8 weeks., Methods: Rikkunshito responders were defined by using a global patient assessment. Candidate predictors included age, gender, smoking, alcohol consumption, body mass index, comorbidity, Helicobacter pylori infection, plasma levels of acyl ghrelin and des-acyl ghrelin, severity of dyspeptic symptoms, FD subgroup, previous medication, and the type of recruiting institution (clinic or hospital). We calculated hazard ratios (HRs) by using Cox regression analysis with the factors that were indicated to be associated with responders., Results: We assigned 83 and 42 patients to responder and non-responder categories, respectively. Lack of alcohol consumption (HR, 2.04; 95% confidence interval, 1.08-3.88) and low plasma des-acyl ghrelin levels (< 177 fmol/mL; HR, 2.42; 95% confidence interval, 1.24-4.73) were significantly associated with the efficacy of rikkunshito. Lack of alcohol consumption was associated with the efficacy of rikkunshito especially among H. pylori-infected participants. On the other hand, the low plasma des-acyl ghrelin was associated with the efficacy of rikkunshito especially among H. pylori-negative participants., Conclusions: A low baseline level of plasma des-acyl ghrelin was associated with an increased treatment efficacy of rikkunshito against FD. Lack of alcohol consumption was also clinically useful for predicting the response to rikkunshito., (© 2015 Journal of Gastroenterology and Hepatology Foundation and John Wiley & Sons Australia, Ltd.)
- Published
- 2016
- Full Text
- View/download PDF
248. Evaluation of the lipopolysaccharide-induced transcription of the human TREM-1 gene in vitamin D3-matured THP-1 macrophage-like cells.
- Author
-
Hosoda H, Tamura H, and Nagaoka I
- Subjects
- CCAAT-Enhancer-Binding Proteins genetics, Cell Line, Tumor, Humans, Macrophages metabolism, Myeloid Cells drug effects, Promoter Regions, Genetic drug effects, Promoter Regions, Genetic genetics, Proto-Oncogene Proteins c-fos genetics, Proto-Oncogene Proteins c-jun genetics, RNA, Messenger genetics, Transcription Factor AP-1 genetics, Transcriptional Activation drug effects, Transcriptional Activation genetics, Transfection methods, Triggering Receptor Expressed on Myeloid Cells-1, Cholecalciferol metabolism, Leukemia, Monocytic, Acute genetics, Lipopolysaccharides pharmacology, Macrophages drug effects, Membrane Glycoproteins genetics, Receptors, Immunologic genetics, Transcription, Genetic drug effects, Transcription, Genetic genetics
- Abstract
Triggering receptor expressed on myeloid cells-1 (TREM-1) plays a role in inflammation by augmenting inflammatory responses through the production of pro-inflammatory cytokines. TREM-1 is expressed in mature macrophages, and is upregulated by stimulation with bacterial components, such as lipopolysaccharide (LPS). In the present study, the regulatory mechanisms responsible for the transcription of the human TREM-1 gene were examined using a human monocytic cell line (THP-1 cells). Reverse transcription-polymerase chain reaction (RT-PCR) revealed that TREM-1 mRNA was constitutively expressed at a low level in resting cells, and that its expression was upregulated by treatment with vitamin D3 (VitD3), but not by LPS. Importantly, TREM-1 mRNA expression was further upregulated by stimulation of the VitD3‑treated THP-1 cells with LPS. In addition, a luciferase reporter assay revealed that the serum response element (SRE) was involved in VitD3-induced promoter activity, whereas the activator protein-1 (AP-1) sites participated in the VitD3- and LPS-induced promoter activity. Of note, the CCAAT-enhancer-binding protein (C/EBP) site contributed not only to basal, but also to VitD3- and LPS-induced promoter activity. Transfection with transcription factor oligodeoxynucleotide (ODN) decoys indicated that transcription factors of the C/EBP and AP-1 families are likely involved in the basal, as well as in the VitD3- and LPS-induced TREM-1 transcription. Western blot analysis indicated that, of the members of the C/EBP family, C/EBPα was constitutively expressed in resting cells; its expression was enhanced by treatment with VitD3 and was further increased by treatment with VitD3 and LPS. Moreover, the expression of c-Fos and c-Jun (members of the AP-1 family) was augmented by treatment with both VitD3 and LPS. These observations indicate that members of the C/EBP family participate not only in basal, but also in the VitD3- and LPS-induced promoter activity of the human TREM-1 gene, and that members of the AP-1 family are involved in the VitD3- and LPS-induced promoter activity.
- Published
- 2015
- Full Text
- View/download PDF
249. Exacerbation of bleomycin-induced injury by lipopolysaccharide in mice: establishment of a mouse model for acute exacerbation of interstitial lung diseases.
- Author
-
Kimura T, Nojiri T, Hosoda H, Shintani Y, Inoue M, Miyazato M, Okumura M, and Kangawa K
- Subjects
- Analysis of Variance, Animals, Biopsy, Needle, Blood Gas Analysis, Bronchoalveolar Lavage Fluid, Disease Models, Animal, Enzyme-Linked Immunosorbent Assay, Immunohistochemistry, Kaplan-Meier Estimate, Lung Diseases, Interstitial chemically induced, Lung Diseases, Interstitial mortality, Mice, Mice, Inbred C57BL, Pulmonary Edema pathology, Pulmonary Edema physiopathology, Random Allocation, Survival Rate, Tomography, X-Ray Computed methods, Bleomycin pharmacology, Disease Progression, Lipopolysaccharides pharmacology, Lung Diseases, Interstitial diagnostic imaging, Lung Diseases, Interstitial pathology
- Abstract
Objectives: Interstitial lung disease (ILD) is sometimes seen in patients with primary lung cancer. Therapeutic interventions for lung cancer patients with ILD sometimes provoke acute exacerbation (AE) of pre-existing lung disease. Although postoperative AE after lung resection is a potentially fatal complication, prophylactic treatments have yet to be established. Prophylaxis for postoperative AE is imperative for thoracic surgeons. However, no animal models for preclinical research into postoperative management and prophylactic interventions for AE of ILD have been developed. The objective of this study was to establish a new mouse model of AE of ILD, for further investigation of prophylactic interventions., Methods: C57BL/6 mice were intratracheally administered bleomycin (BLM, 1 mg/kg) or saline on Day 0 to induce pulmonary fibrosis, and lipopolysaccharide (LPS, 0.5 mg/kg) or saline to induce inflammatory stimulation on Day 7. Mice were divided into four groups: control group; LPS group; BLM group and BLM + LPS group. Histological changes and computed tomography (CT) images of the lung, lung water content, oxygen partial pressure (pO2) of arterial blood and cell counts and inflammatory cytokine levels in bronchoalveolar lavage fluid (BALF) were assessed on Day 8. Survival rates were also determined., Results: In the BLM + LPS group, chest CT showed diffuse ground-glass opacities, and pO2 was significantly decreased. The most severe inflammatory reaction was evident in the BLM + LPS group, with increased infiltrating cells on histopathology and increased lung water content. Total cell and neutrophil counts and levels of cytokines such as monocyte chemoattractant protein-1, interleukin-6 and keratinocyte chemoattractant in the BALF were significantly elevated in the BLM + LPS group. These findings mimic human AE of ILD. Furthermore, survival curves demonstrated that the BLM + LPS group had the lowest survival rate among all groups., Conclusions: A new mouse model of AE of ILD was developed. This model represents an attractive experimental method for preclinical research of postoperative management and prophylactic interventions for AE of ILD in lung cancer patients., (© The Author 2015. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
250. Establishment and characterization of a novel orthotopic mouse model for human uterine sarcoma with different metastatic potentials.
- Author
-
Kawabe S, Mizutani T, Ishikane S, Martinez ME, Kiyono Y, Miura K, Hosoda H, Imamichi Y, Kangawa K, Miyamoto K, and Yoshida Y
- Subjects
- Animals, Cell Line, Tumor, Female, Glucose Transport Proteins, Facilitative metabolism, Glucose-6-Phosphate analogs & derivatives, Glucose-6-Phosphate pharmacokinetics, Humans, Lung Neoplasms metabolism, Mice, Mice, Nude, Positron-Emission Tomography, Sarcoma metabolism, Sarcoma pathology, Transcription Factors metabolism, Troponin T metabolism, Tumor Cells, Cultured, Uterine Neoplasms metabolism, Disease Models, Animal, Lung Neoplasms secondary, Sarcoma genetics, Sarcoma secondary, Uterine Neoplasms genetics, Uterine Neoplasms pathology
- Abstract
Uterine sarcomas are rare and aggressive gynecologic tumors with a poor prognosis because of recurrence and metastasis. However, the mechanisms of uterine sarcoma metastasis are largely unknown. To investigate this mechanism, we developed a novel uterine sarcoma tissue-derived orthotopic and metastatic model in KSN nude mice using a green fluorescent protein stably expressed uterine sarcoma cell line, MES-SA. Histological analysis showed that all orthotopic primary tumors were undifferentiated sarcoma. Primary tumors were characterized by high (18)F-fluorodeoxyglucose uptake with a positive correlation to the number of pulmonary metastases. In addition, we generated uterine sarcoma cell sublines with high or low metastatic potentials by serial in vivo selection. Microarray analysis between orthotopic tumors with high and low metastatic potentials revealed differential expression of genes related to cell proliferation and migration (TNNT1, COL1A2, and ZIC1). Our model would be useful to compensate for the limited clinical cases of uterine sarcoma and to investigate the molecular mechanisms of metastatic uterine sarcoma., (Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.)
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.